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Nuclear magnetic resonance (NMR) spectroscopy is a proven technique for protein 
structure and dynamic studies, typically requiring the incorporation of stable magnetic isotopes to 
improve sensitivity and assign resonances.  Degenerate levels of 13C-incorporation have been the 
biggest obstacle for mass spectrometry-assisted assignment of 13C-dimethylamine resonances in 
nuclear magnetic resonance spectroscopy (NMR).  Reductive 13C-methylation is an alternative 
labeling method for proteins not amenable to bacterial host overexpression.  Because reductive 
13C-methylation adds sparse, isotopic labels, traditional methods of assigning the NMR signals are 
not applicable.  The research presented in the first part of this dissertation explores several methods 
used to break the degeneracy in 13C-labeling of lysozyme.  To overcome the degeneracy in labeling 
lysozyme with the reductive methylation reaction, we investigated two methods: 1) reductive 
methylation in the presence of 18-crown-6-ether (18C6) and 2) reductive methylation using 
multiple reducing agents.  To assign the - and -dimethylamine resonances of the N-terminal 
lysine residue of lysozyme, a non-destructive Edman degradation method was explored.  The 
second part of this research discusses an alternative assignment method based on mass 
spectrometry to aid in the assignment of the NMR signals from reductively 13C-methylated 
proteins.  Because assignment is increasingly difficult when lysine is the N-terminal residue of the 
protein, one method is described to identify the NMR resonance of the 13C-methyls associated with 
both the N-terminal α-amine and the side chain ε-amine.  The NMR signals of the N-terminal α-
dimethylamine and the side chain ε-dimethylamine of hen egg white lysozyme Lys1 are identified 
in 1H-13C heteronuclear single-quantum correlation spectra.  Protein chemical modification is a 
well-established field that continues to impact leading research today including glycomimetics and 
cross-linking of proteins.  Current protein chemical modifications like polyethylene glycol are 
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proven useful for increasing the lifetime of several therapeutic enzymes but are also toxic to the 
body.  In the last chapter, we present the use of sugar derivatives as a possible less toxic alternative 
for synthetic glycoproteins.  The synthesis of a protein modifier is described and preliminary data 




CHAPTER 1 INTRODUCTION 
 
1.1 Protein Structure and Stability  
1.1.1 Protein Structure 
Proteins are macromolecules assembled from the arrangement of covalently-linked amino 
acids.  Twenty standard amino acids compose the structures of proteins and are critical to all living 
elements used throughout nature and the human body.  Structurally, each amino acid contains four 
common features: 1) α-carbon, 2) an amine, 3) a carboxyl, and 4) a side chain or R group (Figure 
1.1).  
 
Figure 1.1.  Diagram of an amino acid 
Three components (i.e. amine, carboxyl, and side chains) are covalently bound to the α-
carbon, which is the central atom for each amino acid, causing the amino acids to be asymmetrical, 
or chiral.  Nineteen of the twenty common amino acids follow this pattern, giving them the ability 
to exist as two non-superimposable mirror forms, stereoisomers, in nature.  The stereoisomers are 
designated D (dextro, right) or L (levo, left) for the direction they rotate the plane of a beam of 
polarized light (Figure 1.2).  The amino acids found in protein and peptide structures are 
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synthesized by forming peptide bonds (or amide bonds) during condensation reactions between 
the α-carboxyl group and the α-amine group of adjacent amino acids.  A peptide is a compound 
consisting of at least 2 amino acids bound by a peptide bond.  Oligopeptides are peptides consisting 
of 10 or fewer amino acids.  Polypeptides are peptides with more than 10 amino acids, and proteins 
are polypeptides with more than 50 amino acids.  All proteins translated in the ribosome are 
constructed with L-amino acids, although, a few D-amino acids are found in proteins that undergo 
post-translational modifications. 
 
Figure 1.2.  Mirror image pair of L-Cysteine and D-Cysteine.  The two are not identical; they 
cannot be superimposed. 
Amino acids range in charge, polarity, hydrophilicity, and hydrophobicity, which results 
in proteins with varying affinities to polar or nonpolar solvents (Figure 1.3).  For example, when 
a protein is dissolved in aqueous solution at a particular pH, the charged terminal amine and 
carboxyl groups on a protein can react with either acids or bases.  Not only does this feature make 
proteins ampholytes, it also classifies them as zwitterions since the side-chain moiety can exist as 
either neutral or as positively or negatively charged molecules.  Amino acids that can be positively 




Figure 1.3.  The 20 common amino acids group according to side chain (green) functionality. 
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Moreover, the functional groups within proteins allow it to act as an acid (a proton donor) or a 
base (a proton acceptor).  When the sum of charges from the proton donors (+H3N-CHR-COOH) 
and proton acceptors (+H3N-CHR-COO
-) are equal, the net charge is zero.  The pH of the aqueous 
media that results in a zero net charge is known as the isoelectric point (pI).  The pH of a solution 
affects the protein’s charge and aqueous solubility.  Therefore, when proteins are suspended in 
media at a pH below its isoelectric point, the protein has a net positive charge; whereas, protein 
solutions with pH values above its isoelectric point results in a negative net charge.  In either case, 
the protein is charged and dissolved in the aqueous media.  However, at pH values within 1 
deviation of the pI, proteins are typically unstable and will precipitate. 
Acid-dissociation constants (pKa) represent the pH-dependent characteristics of the 
functional groups (carboxyl, amino, and any ionizable side chain) within the protein (Table 1.1).  
Each ionizable functional group has a specific pKa value that corresponds to a pH in which the 
concentration of the protonated form is equal to that of the unprotonated form.  When the pH of 
the solution is below the pKa of the ionizable group, the protonated species dominates and it is 
capable of acting as an acid by donating a proton.  When the pH of the solution is above the pKa, 
the unprotonated species dominates allowing the functional group to act as a proton acceptor.  Each 
amino acid has at least two pKa values associated with its -amine and -carboxyl groups, which 
can be determined by titration curves.  Amino acids that do not have an ionizable functional group 
on its side chain exists as a zwitterion, a neutral molecule with both positive and negative charges, 
in solution at pH values between the pKa values of the carboxyl and amine groups. 
The chemical properties of proteins affect its propensity to be in contact with polar or 
nonpolar molecules.  More particularly, the side chains govern the interactions the protein has with 
solvents.  Polar and charged amino acids such as serine, threonine, asparagine, aspartate,  
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Table 1.1.  Acid dissociation constants (pKa), basic constituents, and isoelectric points (pI) of 
free amino acids at 25°C.  Horton, H. R.; Moran, L. A.; Scrimgeour, K. G.; Perry, M. D.; Rawn, 
J. D., Principles of Biochemistry. 4th ed.; Pearson Prentiss-Hall: Saddle River, New Jersey, 
2006. 
Amino Acid Acid Dissociation Constant (pKa) 
Isoelectric 
Point (pI) 
 Carboxyl Group Amino Group Side Chain  
Glycine 2.34 9.60 - 5.97 
Alanine 2.34 9.69 - 6.00 
Valine 2.32 9.62 - 5.96 
Leucine 2.36 9.60 - 5.98 
Isoleucine 2.36 9.60 - 6.02 
Methionine 2.28 9.21 - 5.74 
Proline 1.99 10.60 - 6.30 
Phenylalanine 1.83 9.13 - 5.48 
Tryptophan 2.83 9.39 - 5.89 
Serine 2.21 9.15 - 5.58 
Threonine 2.09 9.10 - 5.60 
Cysteine 1.96 10.28 8.18 5.07 
Tyrosine 2.20 9.11 10.07 5.66 
Asparagine 2.02 8.80 - 5.41 
Glutamine 2.17 9.13 - 5.65 
Aspartic Acid 1.88 9.60 3.65 2.77 
Glutamic Acid 2.19 9.67 4.25 3.22 
Lysine 2.18 8.95 10.5 5.98 
Arginine 2.17 9.04 12.48 10.76 
Histidine 1.82 9.17 6.00 7.59 
glutamine, glutamate, histidine, lysine, arginine, cysteine, and tyrosine result in proteins that have 
energetically favorable interactions with polar solvents like water.  These interactions are due to 
the hydrogen bonding capabilities of polar amino acids.  The hydrophobic amino acids (e.g. 
alanine, valine, leucine, isoleucine, proline, phenylalanine, and tryptophan) are typically 
inaccessible to polar solvents and have a lower propensity to interact with water.  Although protein 
structure and classification will be discussed in the next section, these amino acids control protein 
structure in aqueous Solvents and facilitate protein solubility in nonpolar solvents.    
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1.1.2 Classification of Protein Structure 
The structural components of each protein have a critical role in its size, conformation, 
stability, and function.  In particular, the assembly of amino acids, amino acid sequence, and their 
impact in higher-order protein structure and function were first investigated by William Atsbury 
(1933),1 Walter Kauzmann (1946),2 Kaj Linderstrom-Lang (1949),3 Linus Pauling et al. (1951),4 
and Christian Anfinsen (1954).5  Protein structures are generally classified into four groups: 
primary (1º), secondary (2º), tertiary (3º), and quaternary (4º).  The linear sequence of amino acids 
results in the primary structure of a protein.  Conventionally, the order of amino acids is interpreted 
from the N-terminus to the C-terminus, or the terminal amine to the terminal carboxyl group of 
the protein, respectively.  Intra-molecular forces (i.e. hydrogen bonding, Van der Waals, and 
dipole-dipole) among amino acid residues result in the formation of secondary structure.  
Examples of secondary structures are alpha helix, beta sheet, random coil, turns, and loops.  Studies 
premised from the original work of Pauling (1951) have demonstrated that protein structure (e.g. 
α-helix and β-sheet) and subsequent folding are preferentially formed from the properties of amino 
acids in aqueous solution.4  As a result, α-helices and β-sheets (Figure 1.4) are the two most 
common, stable secondary structures that exist.  Tertiary structure is the three-dimensional shape 
formed mainly by hydrophobic interactions.  In aqueous solutions, the hydrophobic amino acids 
orient themselves away from the water resulting in higher order folding.  As the protein chain 
folds, this situates some nonpolar amino acids in the core of the protein in closer proximity to 
others allowing disulfide and salt bridges to be formed and stabilize the structure.3 The 
accumulation of intramolecular forces results in the protein’s native conformation, which is the 
state that a protein is most active and functional.  Quaternary structure results from the 








multimers (i.e. dimer, trimer, tetramer, etc.).  Similar to tertiary structures, quaternary structures 
are stabilized by non-covalent interactions.  Many known functional biological proteins exist as 
quaternary proteins (i.e. hemoglobin, viral capsids, ion channels, DNA polymerase, etc.).  Changes 
to protein structure or conformation will be discussed in the next section. 
1.1.3 Protein Denaturation 
Protein denaturation or unfolding is the process in which the secondary and tertiary 
structures of a protein, in its native (folded) state, become unfolded.  Since the native conformation 
is usually the most water soluble, denatured proteins typically exhibit changes in solubility.  
Several approaches have been used to denature proteins.6-7  For most proteins in solution, the 
equilibrium between the native conformation and the unfolded state is modulated by pH, ionic 
strength, and temperature of the aqueous surroundings or the addition of co-solvent or chaotropic 
agents.7  The unfolded state is a result of losses in secondary and tertiary structure by disrupting 
intramolecular interactions.  In particular, amino acids bound by disulfide and salt bridges, polar 
side chains and solvent, and hydrogen-bonded amino acids are affected.8  It must be noted that this 
process is not strong enough to cleave peptide bonds; as such, the primary structure remains 
unchanged.  
 Heat is used extensively to reversibly (temporarily) and irreversibly (permanently) 
denature proteins.  Exposing proteins to increasing temperatures weakens the protein structure by 
first affecting the long-range interactions in the tertiary structure.  Depending on the proteins’ 
thermal stability, heat increases the kinetic energy of the macromolecule.  When the kinetic energy 
surpasses the hydrogen bond and van der Waals forces, increased vibrations and long-range 
flexibility permit water to interact with the nonpolar regions of the protein, typically through the 
backbone carbonyl and amine groups.  The effect of water on the hydrophobic regions of the 
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protein results in unfolding, at the cost of the protein minimizing its free energy and exposing as 
many polar amino acids to offset the high entropy caused by the exposed hydrophobic residues.  
Since both short and long-range interactions are disturbed, the protein may or may not return to its 
native, functional conformation.  In the case of the former, cooling allows the protein to return to 
its native state.  However, in irreversibly heat-denatured proteins, the kinetic barriers required to 
return to the native conformation must be overcome, typically in a sequential fashion to reach the 
proper conformation.  Calorimetric methods are the premier approaches to determine the 
thermodynamic transitions that proteins undergo when heated.9  Lyubarev and Kurganov 
extensively covered the use of calorimetry and other approaches to understand thermal 
denaturation of proteins.10  In particular, if the original thermal character is observed after reheating 
the sample then the protein is considered reversible; whereas, irreproducible thermal transitions 
observed in calorimetric curves indicate an irreversible denaturation induced by heat.  
Acids and bases are also used to disrupt bonds between amino acids in the tertiary structure.  
As alluded to earlier in Section 1.1, pH is critical to the stability and structure of proteins since it 
affects its charge distribution and intramolecular forces.  This type of denaturation is mostly 
attributed to the distortion of charge balance on the protein.7,11  In water, proteins fold with the 
aggregation of the hydrophobic residues internally, exposing the polar residues to interact with the 
solvent.  During this process, salt bridges form between acidic and amine side chain ionic pairs in 
close proximity.  These ionic parings are stronger and have a bigger role in stabilizing the protein 
structure than the polar side chain interactions with the solvent.  In extreme acidic conditions, the 
acidic side chain of the salt bridge is neutralized and the protonated amine associates to the anion 
of the acid.  This process creates an overabundance of positive charges, leading to repulsion of the 
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charged sites and the structure of the protein is destroyed.  The effects of base are analogous to the 
use of acid but causes an excess of negative charges. 
 Alcohols and other organic solvents, with dielectric constants lower than water, are also 
known to denature proteins.12-14  Not only do these solvents increase the strength of the electrostatic 
interactions between the water molecules and the charged residues in the protein (increased organic 
solvent results in a smaller hydration sphere around the protein), but the hydrophobic bonds 
governing the tertiary protein structure weaken allowing for greater interactions between the 
organic solvent and protein.  In this case, the degree of folding depends largely on the properties 
of the primary structure and the concentration of organic solvent introduced into the system.  For 
example, large amounts of organic solvent would typically result in further denaturation as 
compared to larger amounts of aqueous solvent.  This effect was evident in the investigation 
reported by Voets et al. (2010), in which smaller fractions of DMSO in water were required to 
maintain lysozyme stability.15  At concentrations exceeding 70% DMSO, lysozyme became 
unfolded and collapsed and was attributed to the impact of the protein microenvironment at 
varying concentrations of DMSO, since it strongly disrupts hydrogen bonds with the water and 
polar amino acids.  Ultimately, the apolar components of the protein became unfolded and better 
dissolved in the solvent mixture.  In conditions in which solvent exchange occurs slowly, the 
protein would be able to maintain stability as it adjusts to the conditions in which it is exposed.  
However, this phenomenon is not accurate for every protein and solvent mixture studied.  
Griebenow and Klibanov (1996) reported that an organic and aqueous solvent mixture was actually 
detrimental to the secondary structures of lysozyme and subtilisin.16  In their study, the presence 
of polar, pure organic (anhydrous) solvent did not change the protein secondary structure; whereas 
organic-aqueous solvent mixtures resulted in losses of -helical content.16  However, due to the 
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limited solubility of proteins in organic solvents, they are typically not used as denaturants.  As 
such, the incorporation of chaotropic agents is a preferred method to denature proteins when using 
chemical additives. 
 Chaotropic agents, such as urea and guanidine hydrochloride, are used to denature proteins 
by disrupting the hydrogen-bonding network between water molecules and weakening the 
hydrophobic interactions within the protein structure.11,17  These agents specifically interfere with 
the stability of the hydrophobic regions of the protein by increasing the entropy of the system after 
exposing the hydrophobic amino acids to the surrounding aqueous environment.  As a result, the 
hydrophobic amino acids become solubilized and the native conformation becomes destroyed.  In 
addition to urea and guanidinium chloride, univalent salts are effective protein denaturants.  Zhang 
and Cremer (2010) extensively reviewed the interactions of proteins with many osmolytes and 
anions that follow the Hofmeister series,18-19 which has been known to be a useful guide to 
determine effective protein-dissociating chaotropes.17,19-22 For example, Adebowale and 
Adebowale (2007) found that the solubility of Mucuna pruriens protein isolates increased when 
placed in chaotropic solutions that followed the Hoffmeister series.23-24  In depth details regarding 
the molecular-level interactions of chaotropes and macromolecules using sodium dodecyl sulfate, 
guanidinium chloride, and urea, as example agents known to disrupt protein structure, can be found 
in reviews published by Alonso and Dill (1991) and Zhang and Cremer (2010).25-26 
1.2 Protein Modification  
Protein modification plays an essential role in the production of target proteins and peptides 
and the understanding of their biological functions and applications.  Rooted in the last decade of 
genomics research, the journey from gene to protein revealed the complexity, diversity, and 
abundance of proteins that encompass the human proteome.  While it is estimated that 
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approximately 25,000 genes comprises the human genome,27 it is believed that the human 
proteome consists of over 1 million proteins.28  Evidenced by studies showing that a single gene 
can encode multiple proteins, the complexity of understanding protein production, function, and 
application is further facilitated by protein post-translational modifications (PTMs).29 To 
understand the occurrence of PTMs, the processes (i.e. transcription and translation) in which a 
gene is expressed to produce proteins will be briefly discussed. 
1.2.1 Protein Synthesis 
The first step of gene expression, which occurs in the cell nucleus, is known as 
transcription.  Transcription is the genetic process in which RNA polymerase copies DNA into a 
complementary antiparallel RNA strand to form a transcription unit that encodes one gene.  
Encoded genes for protein synthesis use messenger RNA (mRNA) to convey genetic information 
out of the nucleus to the ribosomal complex in the cytoplasm where the second step of gene 
expression called translation occurs.  Translation is a four-step process (i.e. initiation, elongation, 
translocation, and termination) in which clusters of three mRNA bases along its sequence are 
translated as codons to link individual amino acids.  Transfer RNA (tRNA) carries the amino acids 
as directed by the codons to the ribosome, which assembles the protein until it encounters three 
bases that code for protein assembly to stop.  Post-translational modifications are events in which 
the amino acids produced within the ribosome are enzymatically converted into a non-standard 
amino acid.  Typically, PTMs include, but are not limited to, proteolysis, acetylation, lipidation, 
glycosylation, ubiquitination, phosphorylation, and methylation.  Because of this, the twenty 
amino acids commonly observed in proteins have now been extended to more than 400. 
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1.2.2 Post-translational Modification 
Post-translational modification of proteins can be summarized into three major categories: 
1) modifications that involve peptide bond cleavage and formation, 2) modifications that involve 
amino (N-) and carboxyl (C-) terminal amino acids, and 3) modifications that involve specific 
amino acid side chain moieties.30-31  Peptide bond cleavage, or proteolysis, is the most common 
protein modification.  Typically, large precursor proteins or polyprotein chains are assembled in 
the ribosomal complex and later cleaved by various enzymes to form their final active structures.  
Since many proteins have been found to begin with an N-terminal amino acid other than L-
methionine, which is usually the first amino acid because its codon is the start codon for protein 
synthesis, it is believed that peptide cleavage occurs soon after protein synthesis.32  Peptide 
cleavage directly affects protein folding by exposing specific structural domains of proteins that 
dominate their tertiary structures and, if enzymes, their ability to interact with a substrate.33  
Therefore, the consequence of cleaving specific polypeptide bonds is the production of a new, 
diverse set of proteins.   
 Of the several PTMs, acetylation is the most common irreversible and reversible 
modification to occur at the N-terminal amino acid.  N-terminal acetylation is a chemical reaction 
that occurs in more than 80% of human and bacterial proteins in which an acetyl functional group 
is used to replace L-methionine after it has been cleaved by methionine-aminopeptidase (MAP).  
Although this type of reaction is classified as a PTM, it can occur while the protein is still 
undergoing synthesis in the ribosomal complex, or co-translationally.34  In many instances, N-
acetylated proteins have L-alanine, glycine, or L-serine as N-terminal residues.  However, proteins 
are typically acetylated on L-lysine residues to regulate gene transcription, although many 
cytoplasmic proteins have been reported to undergo acetylation.34  The exact biological 
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significance of N-acetylation is unclear, but is postulated to protect the protein from cleavage by 
N-terminal peptidases.31 
Other N-terminal addition reactions involve lipidation and glycosylation.  Lipidation is a 
method in which proteins are modified by the addition of fatty acids so they can be taken in by 
organelles in the plasma membrane.35  There are four types of lipidation PTMs, but only N-
myristoylation is specific to the N-terminus.  This type of lipidation functionalizes an amino acid 
with a myristoyl group to change the localized hydrophobicity of the protein and drive its affinity 
and ability to dock the protein to the endoplasmic membranes.34,36  N-myristoylation is initiated 
by N-myristoyltransferase (NMT) using myristoyl-CoA as the substrate to attach the myristoyl 
group to the N-terminal glycine.  This PTM also requires that L-methionine be cleaved using MAP 
before the myristoyl group can be added. 
There are several types of C-terminal modifications, but ubiquitination is the most common 
PTM.  Ubiquitination is a three-step, cascading enzymatic modification in which one or more 
ubiquitin polypeptides are covalently attached to side chain amino groups of lysine through the C-
terminal glycine of ubiquitin.37-38  Ubiquitin, a 76 amino acid protein consisting of seven lysine 
residues, plays a key role in cellular processes.39  The roles of each lysine residue in this PTM have 
yet to be elucidated, but many studies have concluded that K48 and K63 primarily regulate protein 
degradation and coordinate protein processes, respectively.40-41 
All other PTMs, like glycosylation, phosphorylation, and methylation, also result in the 
addition of small molecules to the protein.  Glycosylation, which can occur during co- or post-
translational modification, are a series of reactions in which carbohydrate groups are attached to 
protein moieties.11  Specifically, N-linked glycosylation involves the covalent attachment of a 
complex, branched oligosaccharide consisting of N-acetylglucosamine (GlcNAc), mannose, 
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different sugars, and a terminal sialic acid to the side chain of an L-asparagine residue.11  The 
synthesis of N-linked oligosaccharides for plants, animals, and single-celled eukaryotes begins in 
the rough endoplasmic reticulum with the basic scaffold: three glucose, nine mannose, and two 
GlcNAc molecules.  These oligosaccharides help to direct the newly formed glycoprotein to 
specific locations in the cell or help with stability and folding of proteins.42  When on the surface 
of eukaryotic cells, glycoproteins facilitate cell-cell attachment.  Overall, glycosylation reactions 
contribute greatly (>50% of human proteins are glycosylated43) to the variety of proteins in the 
human proteome because all four components unique to glycosylation (i.e., glycosidic bond, 
glycan composition, branching structure of the glycan, and the length of the oligosaccharides 
attached to the protein) can be altered.42-43  Phosphorylation is an enzymatic modification in which 
a phosphoryl group is added to the hydroxyl side of L-serine, L-tyrosine, or L-threonine residues 
transferring the regional hydrophobicity of a protein to one of greater polarity and 
hydrophilicity.44-45  Also catalyzed by enzymes, methylation usually incorporates one or more 
methyl groups to an L-lysine or L-arginine residue.46  Like all other PTMs, incorporation of either 
phosphoryl or methyl groups onto a protein helps to govern cellular regulatory signaling.39 
1.2.3 Recombinant Protein Expression 
Proteins are the foundation for virtually every cellular activity and knowledge of their roles 
in cell processes is essential to understanding biological systems.  The vast diversity of the human 
proteome necessitates the ability to acquire proteins in their native conformation, at usable 
quantities and lower costs, and ideally from the original source.  Substantial progress in genetic 
engineering has allowed proteins to be expressed from recombinant DNA in both prokaryotic and 
eukaryotic systems for application-driven structural and activity studies.  
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Recombinant protein expression is the ability to exchange or transfer unmodified DNA 
from one host to another to produce proteins.  There are several attractive reasons for which 
recombinant technology is used: 1) proteins can be produced in organisms that have fast growth 
rates and are easy to cultivate;47 2) promoters can be used to potentiate the yields of recombinant 
protein by allowing the target protein to be overexpressed relative to its other cellular 
components;48 and 3) translational fusion can be incorporated to facilitate protein purification.49-50  
Ultimately, recombinant protein expression provides a medium to overcome low yields of newly 
discovered proteins so that they can undergo sequencing, biochemical, and structural studies.  
The host used to express recombinant proteins for structural analysis is usually Escherichia 
coli because altering its genetic information is relatively easy and inexpensive.47  Extensive use of 
E. coli in bacterial genetics has resulted in a multitude of systems available to facilitate its utility 
in recombinant protein expression.51  Recombinant expression to obtain high yields of purified 
proteins usually occurs when the DNA sequence of a target protein is cloned into a vector and 
subsequently transformed into the host cell.  The bacterium uses glucose and ammonium chloride 
as carbon and nitrogen sources, respectively, to produce the necessary amino acids to express the 
proteins encoded in the vector.11  Although the impact of this technology has been extended to the 
development of therapeutics and diagnostic kits, among many others, this aspect of recombinant 
protein expression usually occurs after the protein has been fully characterized.  Recombinant 
protein expression can also be used to incorporate labels in the protein that allow for complete 
characterization of its structure and interactions with ligands and other proteins to better 
understand its function.29,47,50  Labeling can be achieved by feeding the bacterial host labeled 
carbon and nitrogen so that amino acids with the necessary isotopes can be expressed.  For 
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example, if E. coli is fed 13C-glucose and 15N-ammonium chloride, then the target protein is fully 
expressed with 13C and 15N labels and suitable for structurally characterization by NMR. 
 Despite its many advantages, recombinant expression in bacteria is not amenable to 
eukaryotic proteins that require PTM.51  Since bacteria lack the ability to produce eukaryotic PTMs 
(i.e. glycosylation) and do not contain chaperone proteins (disulfide bonds), there is the likelihood 
that improperly folded proteins would be expressed.47,51  Additionally, recombinant expression 
suffers from incorrectly degraded, rearranged, or poorly expressed proteins when codon usage 
differs between source and host ribosomal complexes.47  These features critically limit the feasible 
use of protein-based applications, especially when these aberrations affect its industrial production, 
safety, and efficacy in therapeutic applications.51-53  As a result, other bacteria and eukaryotic cells 
have also been sourced as hosts for this technology, since it is a rate-limiting step in protein 
structural studies and therapeutic applications.52  To date, no single host exists that allows all 
proteins to be expressed in an active form.47 
With over 300 different types of PTMs, the applicability of incorporating isotopic labels 
via recombinant expression for structural studies of proteins, specifically of unknown structure or 
sequence, is limited.34  It is possible to express these proteins in eukaryotic hosts.  However, since 
eukaryotic cells cannot make all amino acids for protein synthesis like prokaryotic cells, uniform 
isotopic labeling is prohibitively expensive.  Thus, chemical techniques that enable modification 
of proteins are highly attractive tools that allow the roles of amino acids to be evaluated in protein 
structural and activity studies. 
1.2.4 Chemical Modification  
Chemical modifications have been essential to protein structure and activity studies.  Like PTMs, 
chemical derivatization takes advantage of the chemical reactivity of the amino acid side chains to 
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achieve specific functional outcomes after proteins have been isolated and purified.  In fact, an 
understanding of organic chemistry and the reactivity of amino acids has allowed the foundation 
for non-enzymatic and simulated post-translational modifications to be conducted using chemical 
means.  For example, chemistry of amino acids have sought to preserve or alter electrostatic 
charge, increase or decrease hydrophobicity, denature or renature proteins, or incorporate or 
remove specific chemical moieties with the intention to study their role in protein tertiary structure 
and activity.  
Figure 1.5 outlines the experimental approach generally used in the chemical modification 
of proteins and subsequent validation studies.  In summary, targeted amino acids in the protein 
backbone are matched with chemical reagents under optimal reaction conditions.  After the protein 
is reacted, excess reagent is removed and the protein is prepared for biochemical studies.  Then, 
the success of the reaction, site and number of residues modified, and its effects on protein activity 
are studied using various assays and elucidative techniques.  Depending upon findings, 
modifications to the existing experiment are made and repeated to achieve desirable outcomes.  
Earlier attempts of protein modification were once limited by the lack of sensitive  methods,  
accuracy in controlling the number and type of amino acids undergoing reaction, and denaturation 
of the protein.  Yet, the introduction of specialized reagents and advanced methods has permitted 
site-selective chemical reactions of amino acids with better sensitivity and accuracy than before. 
Site-selective chemical modification is a process in which a single amino acid residue is 
covalently derivatized without modifying a second, separate amino acid or disrupting the protein’s 
conformation.  Examples of amino acid functional groups, mainly sulfhydryl residues (cysteine), 
phenols (tyrosine), aromatic heterocycles (tryptophan and histidine), and amines (arginine and 




Figure 1.5.  Flow chart outlining experiments for chemical modification of proteins.  (Adapted 
from Matthews, et al. 54 with permission from Elsevier). 
1.2.5 Side Chain Selective Modifications 
1.2.5.1 Sulfhydryl Residues 
Sulfhydryl residues, also known as thiols or mercaptans, are carbon-bonded molecules 
consisting of a sulfur bonded to a hydrogen (–S-H group).55  Because oxygen and sulfur are in group 
VIA in the periodic table, there are similarities in their reactivities, however, there exist differences 
in the chemical properties of the two because they are on different rows.  For example, oxygen is 
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relatively more electronegative than sulfur, but thiols (-S-H) are more acidic than alcohols (-O-H).  
The general reaction to prepare thiols results from an SN2 reaction between sodium hydrosulfide 
and an alkyl halide.55  Since the thiol product is very nucleophilic, if excess hydrosulfide is used, 
then it will be alkylated again to give a sulfide product (R-S-R).   
 As major component of the amino acid cysteine, these alcohol analogues are one of the most 
reactive amino acid functionalities observed in proteins.11  In fact, thiols are easier to oxidize into a 
dimer than alcohols.  For example, when two cysteine amino acids are in close proximity, they 
readily form a covalent disulfide bond in which the –S-H group is changed into an –S-S- group and 
called cystine.11  The oxidation of cysteine residues to form disulfide bonds is the most common 
naturally occurring post-translational/ chemical modification of proteins, which is critical for protein 
structure and stability.  Also, disulfide linkages can be cleaved to return cystine back to two separate 
cysteine amino acids.   
Because the sulfhydryl side chain is very reactive, a wide variety of reagents are available 
for modification of cysteine residues.  Most of these reagents have reactivities with other side chains.  
However, careful consideration of reaction conditions can afford the necessary selectivity of most 
reactions.  Early studies of cysteine residues used direct alkylation with -iodocarbonyls at varying 
pH values.56-57  Derivatization of these alkylating reagents increased the applicability of this method.  
For example, in the lactose repressor protein, none of the three cysteine residues is reactive 
iodoacetic acid or iodoacetamide, but two of them are modified with 2-bromoacetamido-4-
nitrophenol (BNP).58  Understanding disulfide linkages in PTMs was initiated from the observation 
of spontaneous oxidation of cysteine residues by molecular oxygen.  Although too slow to account 
for rapid rates of disulfide bond formation in the cell, this observation led to the discovery of protein 
disulfide isomerase, a eukaryotic cell catalyst responsible for this activity.  Oxidation of cysteine 
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side chains has been used to form disulfide bridges in proteins and to functionalize cysteine residues 
with small molecules.59  However, these simple reactions are challenged by long reaction times and 
an inability to control the reaction product, where either mixed disulfides or dimers would be 
formed.  One alternative reaction that allows for control of the reaction product is to use Ellman’s 
Reagent (5,5-dithobis(2-nitrobenzoate); DTNB) which has historically been used to quantify 
sulfhydryl content in proteins through disulfide exchange reactions.60  Sulfenyl halides, particularly 
methanethiosulfonates, have improved the reaction time, reduced the reagent quantities, and 
increased the selectivity compared to conventional disulfide formation reactions.54,61 
There are several elements required for the execution of these reactions.  In order for 
disulfide bridges to be formed between thiol groups, the proximity between cysteine residues must 
be favorable and not hindered by neighboring, large side chains.  Also, reaction conditions must be 
favorable in that the cysteine residue can be independently modified without inducing protein 
denaturation.62  Avoidance of denaturation can be a challenge since fundamental studies have 
revealed that most sulfhydryl groups within the protein are submerged in hydrophobic locations, in 
which functionalization most often produces an altered protein structure.62  Disulfides may also 
present some instability in reducing environments thereby limiting their in vivo application with 
high intracellular glutathione concentrations.56  Because of this, the feasibility of known thiol-
selective chemical modifiers and subsequent analyses of modified proteins were limited.  Recent 
methods have approached these challenges by 1) desulfurization of the cysteine residue, 2) oxidative 
elimination of cysteine, or 3) metal-mediated modification of cysteine and its derivatives.56  
Understanding sulfhydryl reactions and its applicability to cysteine and proteins, have promoted 




Some of the most widely observed compounds in nature and industry are alcohols, or 
organic compounds that contain hydroxyl (-O-H) groups in their structure.  Structurally, alcohols 
are similar to water in that they both have sp3  hybridized oxygen atoms, but the bond angle in 
alcohols are larger than the bond angle in water.55  The bond lengths of the hydroxyl moieties are 
approximately the same.  Alcohols differ by the type of carbinol carbon (i.e., carbon conjugated to 
the hydroxyl group) and, depending on its number of functional groups attached, are classified as 
primary, secondary, or tertiary alcohols.55  Compounds that have a hydroxyl group bonded directly 
to an aromatic ring are called phenols.  Phenols have properties similar to the aromatic and alcohol 
component of its structure.  As a result, alcohols have variable solubility in polar and nonpolar 
solvents.  Generally, the hydroxyl proton of alcohols is weakly acidic and can be removed easily 
in the presence of a strong base.55  However, the acid dissociation constants of alcohols vary 
depending on the order of bonding (i.e., primary, secondary, or tertiary) and their subsequent 
reactions.55 
In proteins, only three amino acids contain hydroxyl groups on their side chains, namely 
serine, threonine, and tyrosine.11  Serine, a primary alcohol, is very important in biosynthesis and 
enzyme catalysis reactions.  Threonine is an essential amino acid with a secondary alcohol that 
participates in numerous PTM reactions.  Tyrosine is the only standard amino acid that has a 
phenolic functional group in its side chain, and it participates in signal transduction processes and 
photosynthesis reactions.  Because the hydroxyl group on tyrosine has a lower pKa (pKa ~10) than 
serine or threonine (pKa ~13), it is much more reactive.
63  None of the hydroxyl groups on serine, 
threonine, or tyrosine residues are ionizable. 
Chemical modification of serine or threonine groups is not a trivial task, because neither  
23 
 
amino acid   is a strong nucleophile.  However, their nucleophilicity is greatly improved when 
spatially located near a histidine residue or the hydroxyl group is transformed into an alkoxide 
ion.63  Several literature reports have discussed the use of N-hydroxysuccinimide (NHS) 
derivatization of serine, but since it is dependent on the nature of adjacent amino acids, it has lost 
popularity.63  Attempts to oxidize serine and threonine with carbodiimide in the presence of 
dimethylsufoxide and phosphoric acid resulted in severe protein aggregation.64   
The molecular structure of tyrosine allows for functionalization through aromatic 
substitution or hydroxyl group reactions.  Irreversible modification of tyrosine residues occurs 
when the aromatic ring is functionalized.  Functionalization of the aromatic ring can be easily 
achieved using iodination reactions, but is not ideal for structural studies since it results in changes 
to the protein that affect folding and biophysical properties.54  Functionalization of the hydroxyl 
group is typically the easiest and reversible approach to modify tyrosine, leaving the native 
structure of the protein unperturbed.54  Contrary to serine and threonine, tyrosine residues can be 
modified under mild conditions with high selectivity.62  As a result, there are numerous 
derivatizing agents and chemical conditions available to facilitate tyrosine-based reactions.  For 
example, tyrosine has been modified through esterification, photooxidation, acetylation, nitration, 
and iodination reactions.62,65  In particular, iodination reactions of the hydroxyl group have been 
an essential approach to incorporate iodine radioisotopes (125I and 131I) for protein labeling and 
structural studies.65  Typically, tyrosyl residues that can be iodinated can also be O-acetylated with 
acetic anhydride.  These reactions are not as specific as N-acetylimidazole and 
tetranitromethane reagents because it is very difficult to selectively modify tyrosine (or serine and 
threonine) when carboxylic acid anhydrides preferentially react with primary amines.62-63  Because 
the reagents available to functionalize tyrosine also derivatize other amino acids, it is best to use 
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other approaches to determine the presence, abundance, and function of tyrosine in the protein 
structure.54 
1.2.5.3 Aromatic Heterocycles 
Aromatic heterocycles are cyclic molecules containing a heteroatom such as nitrogen, 
oxygen, or sulfur in its structure.55  Essentially, the number of aromatic heterocycles is substantial 
since they vary in ring size, conjugation, and the number and type of heteroatom included.  There 
are only two standard amino acids that are classified as aromatic heterocycles, histidine and 
tryptophan, which contain imidazole and indole functional groups, respectively. 
Histidine is an essential amino acid with an imidazole side chain, an aromatic five-
membered heterocycle containing two nitrogen atoms.  Since one nitrogen contains a lone pair and 
the other a hydrogen, the basicity of the nitrogens differ, where the unprotonated nitrogen has 
higher basicity.55  Histidine is important to the catalytic mechanism of many enzymes.  
Functionalization of histidine has been explored using the same reactions executed for phenols, 
namely photooxidation, alkylation, and iodination reactions.54  Initially, photooxidation was not 
specific towards histidine residues since a number of dyes can also oxidize tryptophan, tyrosine, 
cysteine, and methionine.62  The dye, Rose Bengal, seems to be the most specific towards histidine 
residues and has been essential to study the roles of histidines in the active site of enzymes.62  
Alkylation reactions are not very selective towards histidine, but can be improved if a suitable pH 
is used for the reaction.  The histidyl side chain undergoes alkylation in the unprotonated form, 
which requires a pH above 5.  Selectivity for histidine modification is optimum in pH range of 5 
– 7, where the protonated form of other side chain amines dominate to minimize competition.66  
Most importantly, alkylating histidine does not typically alter binding or catalytic efficiency.  
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Iodination reactions preferentially modify tyrosine residues, but can be histidine-selective at 
increased pH values.62 
Tryptophan, another essential amino acid, has a fused, bicyclic indole moiety containing 
one nitrogen.  In general, fused-ring heterocycles have similar properties to simple heterocycles.  
Tryptophan is important in protein synthesis and serves as a biochemical precursor to many 
compounds.  Chemical modification of tryptophan can be achieved through photooxidation, 
iodination, ozonization, and treatment with N-bromosuccinimide.  Overall, these methods show 
poor selectivity to tryptophan since they react with other amino acid residues.54 
Aromatic sulfenyl halides have been shown to specifically and quantitatively modify 
tryptophan residues in strongly acid conditions.67  The only competing reaction is the formation of 
mixed disulfides with cysteine residues.  Additionally, tryptophan residues can be selectively 
functionalized with a formyl group in anhydrous formic acid saturated with gaseous HCl without 
cleavage of peptide bonds.67  Although structure has been shown to be conserved, protein activity 
is most often adversely effected.  The harsh acidic conditions have severely limited the wide spread 
use of sulfenyl halides and formylation in protein structural studies. 
1.2.5.4 Amines 
Amines are compounds containing one or more alkyl or aryl groups bonded to a nitrogen.  
Similar to carbon atoms, amines are classified as primary, secondary, or tertiary depending if they 
have one, two, or three substituents covalently attached to the nitrogen center.55  Overall, amines 
are strongly polar because they have contributing dipole moments from the lone pair, C-N, and N-
R bonds.  As a result, they form hydrogen bonds very easily; however, tertiary amines can only 
act as hydrogen bond acceptors.  In comparison to O-H bonds, amines form weaker hydrogen 
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bonds because the N-H bond is less polar due to nitrogen’s lower electronegativity compared to 
oxygen.55 
Asparagine, glutamine, lysine, and arginine are four standard amino acids with amine-
based functionalities.  Both glutamine and asparagine are amides, and lysine and arginine are a 
primary amine and guanidine, respectively.55  Owing to the strong hydrogen bonding capability of 
these amino acids, one function is to maintain the secondary and tertiary structure of proteins.11  
Each amino acid can also have a critical role in cellular processes and enzyme function. 
Similar to other pursuits to chemically modify amino acids, a variety of reagents have been 
used to functionalize amines.  In particular, lysine can undergone acylation, esterification, 
guanidination, acetoacetylation, carbamylation and arylation reactions.  Most of those reactions 
are limited because of selectivity as threonine, serine, histidine, cysteine, and tyrosine residues are 
chemically derivatized.  Improved selectivity has been achieved with an alkaline pH (i.e. above 8) 
with a number of reagents used for these reactions.  However, elevated pH values can sometimes 
prove to be harsh to the structural integrity of the protein.  Reductive alkylation is a popular method 
to specifically modify lysine residues requiring mild reaction conditions.  Particularly, reductive 
methylation reaction has become the primary method used to study the role of lysine residues in 
protein structure and activity, which is discussed in more detail in the next section. 
1.3 Reductive Methylation of Proteins 
Reductive methylation is a good tool for studying protein structure and function and has 
been used since 1968 to study the roles of specific lysines in biological function.68  This sparse 
labelling method allows for lysines to be chemically modified under slightly basic conditions in 
the presence of a reducing agent and formaldehyde.  The protein N-terminal -amine and the lysyl 
side-chain -amines undergo methylation to produce monomethylamines, which have a slightly 
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higher acid dissociation constant (pKa) compared to the unmodified primary amines.
69   In the 
presence of excess formaldehyde, the monomethylamine readily reacts to produce a 
dimethylamine (Figure 1.6).  Proteins can be isotopically labeled in this manner with the use of 
labeled formaldehyde (13C and 14C) and/or reducing agent (2H and 3H).69-72  Since lysines are polar 
and the side-chains are typically solvent-exposed, it is easy to homogeneously modify most lysines 
by reductive methylation.  Some exceptions are when the lysine is involved in a salt bridge or 
buried in the tertiary or quaternary structures.  The reductive methylation reaction conditions are 
mild, so proteins can be modified without denaturation.  Reductive methylation of proteins is 
usually performed at pH 7.5-10.0; but, in an unpublished study, we found that reductive 
methylation is achievable as low as pH 4.0, extending the applicability of the method.  Another 
attractive feature is the retained charge of the amines with reductive methylation, closely 
maintaining the isoelectric point (pI) of the protein.  Due to the small size of the methyl groups, 
the modification rarely introduces global changes to the protein structure or interferes with its 
activity, the most important feature of reductive methylation. 
 
Figure 1.6.  Reductive methylation reaction.  Reproduced from Roberson et al., All Res. J. Chem, 




1.3.1 Techniques to Study Reductive Methylation of Proteins  
Reductive methylation of proteins has been used to advance many techniques in the study 
of protein structure and function.  Reductive methylation can facility protein crystallization by 
altering the dynamics of the lysyl side-chains through steric and hydrophobic interactions.  Aiding 
protein crystallization is one of the early applications of the reductive methylation reaction and is 
still a major application today.73-74  Rypniewski et. al demonstrated the first high-resolution three-
dimensional (3D) structure of a reductively methylated protein.75  In this work, the structures of 
lysozyme and reductively methylated lysozyme were compared, revealing highly similar 
structures with a root mean squared deviation of 0.40 Å in the backbone atoms (Figure 1.7).  As a 
result, reductive methylation has had a major impact on studying the biophysical properties of 
proteins, especially structure.   
Other techniques, such as bioactivity assays, electrophoresis, and circular dichroism (CD), 
have also benefited from reductive methylation.71,76-79  Electrophoresis is a useful technique for 
assessing biophysical properties, such as the molecular weight and the pI, of medium to large 
proteins.  Reductive methylation has been used in electrophoresis to radiolabel protein samples 
with 14C and 3H, improving the detection sensitivity over the traditional Coomassie Blue staining 
method.80  CD is a technique that can probe the secondary structure of a protein by monitoring the 
differential absorption of circularly polarized light at ultraviolet wavelengths.  Each unique 
combination of amino acids and secondary structure give a distinct absorption fingerprint.  
Reductively methylated proteins have been shown to conserve the structural fingerprint of their 
native counters, which allows CD to be used to analyze the effects of methylation on protein 
binding.81-82  Mass spectrometry (MS) is a powerful technique for analyzing elemental and/or 
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isotopic composition, mass, and chemical structures of proteins and peptides.  Reductive 
methylation has provided many advantages in MS proteomics studies for  
 
 
Figure 1.7.  Comparison of the -carbon positions for native (open circles) and reductively 
methylated (solid circles) hen egg white lysozyme.  Reproduced from (Rypniewski, W.; Holden, 
H.; Rayment, I., Structural consequences of reductive methylation of lysine residues in hen egg-
white lysozyme - an x-ray analysis at 1.8-angstrom resolution. Biochemistry 1993, 32 (37), 9851-
9858.) with permission from the publisher. 
peptide enrichment 83, separations 84, quantitation 85, detection 86, and signal enhancement.87  In 
addition, reductive methylation has been used to identify and associate protein biomarkers with 
breast cancer using a proteomics MS approach.88  MS is also being used to determine tertiary and 
quaternary protein structure,89-90 and the reductive methylation reaction could be used in this way 
to identify structurally protected lysines or the N-terminus. 
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It is well known that protein function is directly related to its structure; hence, the 
importance of probing protein structure on all levels.  Crystallization of proteins was one of the 
early applications of the reductive methylation reaction to protein studies and is still a major 
application today.73-74,91-93  X-ray crystallography was the first to take advantage of reductively 
methylated crystallized proteins to produce a 3D structure.75  Reductive methylation created a 
boom in protein structure determination by X-ray crystallography that is still increasing today with 
the efforts of the Protein Structure Initiative.  While X-ray crystallography is the most successful 
technique in protein structural determination, accounting for approximately 90% of all protein 
structures in the protein data bank, it is not without limitations.  Obtaining high quality crystals is 
difficult, leaving a large number of structures that have yet to be solved.  NMR is another technique 
used to determine the 3-dimensional (3D) structure of reductively methylated proteins.  Reductive 
methylation impacted the field of NMR by the discovery of the associated roles of lysine residues 
with the activity of proteins.94-97  While activity and function of these extensively researched 
proteins were known, these studies identified active site residues that improved understanding of 
protein function and mechanisms of activity.  NMR has the added benefit of analyzing each 
modified lysine in various conditions to study the microenvironment of the lysine side chain, 
intra/intermolecular interactions involving the lysine, and distance restraints associated with metal 
binding sites for 3D structure determination. 
1.3.2 Protein Structure: NMR and X-Ray Crystallography  
NMR has been instrumental in the determination of solution-state protein structure through 
its usefulness in probing the atomic detail of both small and large macromolecules of varying 
complexity up to 80 kDa.98  The technique is based on the production of measureable perturbations 
in a sample’s nuclear magnetization when placed inside a large magnet and exposed to powerful 
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radio frequency pulses of short durations.  NMR resonances can be analyzed from any magnetic 
nuclei that can be resolved by multi-dimensional experiments.  Enrichment of a protein sample 
with these nuclei (i.e. 13C, 15N, and sometimes 2H) is typically required for NMR protein structural 
studies.  To date, NMR is the only method that provides an in-solution snapshot of a protein, 
allowing for a unique perspective in investigating protein structure.  In-solution atomic probing 
not only supplies information about the structure and function of macromolecules, but also 
provides beneficial information about dynamics, conformational equilibria, folding, and intra-
/intermolecular interactions.  A 3D image of a protein sample can be determined through indirect 
interpretation of NMR data.  Typically, amide chemical shifts are used to probe the structure of a 
protein in its native or non-native conformation or as a result of conformational changes that arise 
from partial unfolding or binding.  More sophisticated NMR tools, in combination with chemical 
shifts, reveal information about proton-proton distances through the nuclear Overhauser effect 
(NOE) and the orientation of nuclei within the protein structure with residual dipolar couplings 
(RDCs).  The unique fingerprint of proteins, as observed through various NMR methods, can 
provide exclusive information about the relative spatial locations of different residues in a protein 
sequence and details critical to its function in the presence or absence of ligand or cofactor binding.  
Ligand dependent function is particularly important in applied biological research.  The 
determination of a 3D structure is made possible through NMR measurements, assignments of the 
signals to the respective protein residues, and identification of conformational restraints, the 
determination of a 3D structure can be realized.  In turn, the large amount of data represented by 
common nuclei (1H, 13C, and 15N) in known 3D NMR structures of proteins form the basis for a 
multitude of empirical and semi-empirical correlations with structural parameters. 
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X-ray crystallography has been a vital tool in the advancement of 3D protein structure 
determination.  Not only have the majority of the protein information known to date arisen from 
X-ray crystallography, it has facilitated an in-depth understanding about protein function at atomic 
resolution and structural information at the molecular level of proteins.  This technique is built 
around measured angles and intensities of diffracted X-rays by crystalline atoms.  These 
measurements are then used to create a 3D map of electron densities in the crystal.  The successes 
of X-ray crystallography rely on the ability to crystallize pure proteins or small complexes that are 
easily acquired through recombinant expression.  When considering larger molecules or 
complexes (> 100 kDa), X-ray studies are faced with the daunting requirements of high purity and 
large quantities of protein.  If the protein sample is not stoichiometrically homogenous, it can have 
a detrimental impact on the crystallization of the protein and its crystal diffraction properties.  
Moreover, strong beam intensities and long exposure times are required to obtain high-resolution 
diffraction data on large macromolecules; yet, it is to the expense of severe radiation damage.  
Authors have used cryogenics to reduce radiation damage and increase the lifetime of the crystals 
that encase large macromolecules.99  However, these crystals typically have lattice disorders from 
the rapid freezing process, which is known to reduce the diffraction limit.  This effect is attributed 
mostly to the spatially unequal contraction of the solvent and crystal lattice.  Larger crystals contain 
greater volumes of solvent and larger protein complexes, which increase the obscurity in crystal 
diffraction properties.  To overcome this disadvantage, an X-ray free-electron laser (FEL) is used 
to reduce radiation damage to cryogenized macromolecules and vastly increases the range of 
proteins whose structures can be solved. 
NMR and X-ray crystallography are complementary methods for protein structure 
determination.  Structures solved by both methods typically agree within error.  On the other hand, 
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since solution NMR does not require crystals, it eliminates the potential crystal packing effects 
known to influence the surface structure of a protein.  Despite the incredible amount of structural 
data garnered by X-ray crystallography over the years, the acquisition of crystals and meaningful 
data for macromolecules of differing size and complexity is not a trivial task.  In fact, obtaining 
highly ordered crystals is the limiting step to X-ray structure determination, especially since some 
proteins crystallize with ease while others are quite challenging.  Today, crystallization remains 
more of an art than a science, which is evident from structural genomics and proteomics data that 
state, for approximately 34,000 cloned proteins, less than 4% have been successfully crystallized 
and 2% structurally defined.100  The Protein Structure Initiative reports similar results with a 12% 
success rate from purified to structurally defined protein.  Recent advances in high throughput 
protein NMR methods to quickly assess the foldedness of proteins, which has been correlated to 
the ability to crystallize, show promise in the production of protein crystals that had previously 
eluded crystallizatioin.101-102  
Although limited to relatively smaller proteins and complexes, NMR has the advantage 
over X-ray crystallography in protein dynamics studies.  Proteins are known to be flexible 
molecules with vibrational motions.  Proteins often contain flexible linker regions and/or 
unstructured domains in which NMR can be used to identify them.103  Monitoring protein folding 
is another advantage NMR has over X-ray crystallography.  Hydrogen exchange experiments have 
been used to determine the degree of protection of hydrogen donors due to protein structure.104-106  
Real-time NMR experiments are also used to monitor time-dependent structure formation.107-109  
NMR experiments can give chemically specific microenvironment information such as inter-
atomic distances from nuclear Overhauser effects (NOEs), dihedral angle restraints from J 
couplings, and orientation information from RDCs.110-112  The aforementioned capabilities allow 
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for dynamic studies of proteins using NMR that are not accessible with X-ray crystallography 
through static crystals. 
1.3.3 Protein Samples for NMR 
Protein samples for NMR structural studies can either be isolated from natural sources or 
expressed and purified in either prokaryotic or eukaryotic cells.  Both methods must reproducibly 
yield homogenous protein in milligram quantities.113  Early experiments of NMR structural studies 
relied on proteins that were abundant in natural resources such as myoglobin (blood), lysozyme 
(egg white), and hexokinase (every domain of life from bacteria, yeast, humans and other 
vertebrates).  However, proteins existing in abundant quantities from natural sources are rather 
limited.  Structural studies of proteins isolated from natural sources utilized the proton, which is 
the most essential nucleus in protein NMR.  The 1H isotope is the most sensitive nuclei available 
for protein NMR, existing in 99.985% of all hydrogen in nature.114  Two other useful isotopes for 
protein NMR are 13C and 15N, which exist in nature at 1.1 and 0.37%, respectively, thus requiring 
artificial enrichment to make most modern NMR experiments possible.114  This realization led to 
the emergence of recombinant DNA expression of target proteins in prokaryotic cells, which is 
still the most common source of protein sample for NMR and X-ray crystallography studies 
performed today.  In this process, the DNA sequence of a target protein is cloned into a vector and 
subsequently transformed into the host cell, most commonly Escherichia coli.  The bacteria uses 
glucose and ammonium chloride as carbon and nitrogen sources, respectively, to produce the 
necessary amino acids to express the proteins encoded in the vector.  If the bacteria is fed 13C-
glucose and 15N-ammonium chloride, then the target protein is fully expressed with 13C and 15N 




Recombinant expression in bacteria is not amenable to eukaryotic proteins that require 
post-translational modifications.  This limitation is attributed to the inability of the bacteria to 
produce the eukaryotic post-translational modification and the absence of chaperone proteins 
necessary for proper folding of the target protein.  With over 300 different types of post-
translational modifications, the applicability of bacterial metabolic isotopic labeling is limited.  It 
is possible to express these proteins in eukaryotic hosts, but uniform isotopic labeling is 
prohibitively expensive.  Chemical modification is an alternative approach to incorporate isotopes 
into a target protein from source.  In contrast to protein expression, chemical modification of 
proteins introduces sparse isotopic labels via selective reactions at specific amino acid side chains.  
The chemical modification we have focused on in our research is reductive methylation of lysine 
side chains. 
The most daunting obstacle of the reductive methylation labeling method for NMR 
applications is assigning the resonances to the respective amines.  This labeling method introduces 
sparse 13C-labels that can be used as sensitive probes for protein-protein interactions and distinct 
isolated sites to collect distant restraints from paramagnetic resonance perturbations.  However, 
assignment of the NMR resonances is required before the applications can be realized.  Traditional 
NMR assignment strategies rely on through bond (1 – 4 bond distance) or through space (< 4 Å) 
coupling.  Because the reductive methylation reaction is a sparse labeling technique, through bond 
and through space distances of the 13C-methyls lie outside the capabilities of traditional assignment 
strategies, thus emphasizing the need for an alternative assignment strategy.  Here, we review the 
strategies designed to address the difficult task of assignment and compare results for the 
assignment of reductively 13C-methylated hen egg white lysozyme. 
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1.3.4 NMR Assignment Strategies  
Assignment of the dimethyllysyl NMR peaks was pioneered in 1973 by Bradbury and 
Brown.115  This work established the utility of the dimethylamino group to probe the 
microenvironment of lysines by studying the dimethylamino 1H-NMR peaks of lysozyme as a 
function of gadolinium (III) (Gd3+) concentration.  Through PRE, Gd3+ has a broadening effect on 
NMR peaks, which is inversely related to the distance to the sixth power between Gd3+ and the 
nucleus of interest.  Broader lines were observed as the concentration of Gd3+ bound to lysozyme 
increased, with the group closest to the paramagnetic ion broadening the most.  Assignments made 
with this method were based on a single Gd3+ binding site observed in the x-ray crystal structure 
determined by Blake and Rabstein (not published).  Corroboration of the results with experimental 
pKa values and the 3D structure allowed for assignment of the six 
1H-NMR peaks of the -
dimethyllysines.  It should be noted that lysozyme has six lysines, so seven dimethylamino peaks 
are expected; however, inadequate modification of the N-terminal -amino group, confirmed by 
experimental pKa values, resulted in six peaks.  While absolute assignment of -dimethyllysyl 
peaks was accomplished, this assignment method is limited to proteins that bind paramagnetic ions 
and have known structures with ion-to-methyl distances in the range of 15 – 24 Å.  In 1975, Brown 
and Bradbury published an addendum to this procedure using reductively methylated ribonuclease 
A (RNase-A).116  In this work, the authors compared the pKa values obtained from pH titrations of 
the dimethylamines to those of model compounds to make assignments.  The pKa of the N-terminal 
-dimethylamine of a protein is distinct and typically around 7.0.  The lysyl -dimethylamines fall 
within the range of 9.5 – 11.0, depending on their microenvironment.  When the dimethylamines 
are involved in a salt bridge, the pKa is typically lower.  Because of their distinct pKa values, the 
authors were able to assign the -dimethylamino peak (pKa = 6.6) as well as the -dimethylamino 
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peak of Lys41 (pKa = 8.6), with the aid of the crystal structure, which shows Lys41 in a salt bridge.  
The remaining dimethylamines had pKa values in the range of (10.6 – 11.2) and could not be 
assigned by titration alone. 
 In 1979, Jentoft and Dearborn described new methods for reductive methylation and 
studying the environments of dimethylamines on proteins.117  Reductive methylation of proteins 
with sodium borohydride (NaBH4), the method introduced by Means and Feeney, suffers from low 
efficiency due to the strength of this reducing agent.  In addition to reducing the Schiff base, 
NaBH4 also reduces aldehydes and ketones, thus the reduction of formaldehyde to methanol 
competes with the desired, forward reaction.  Other problems associated with NaBH4 are its strong 
pH dependence (pH 9.0) and the reduction of disulfide bonds.  The method presented by Jentoft 
and Dearborn uses sodium cyanoborohydride (NaCNBH3), a milder reducing agent that does not 
reduce aldehydes or ketones at neutral pH, to reductively methylate proteins.  Additional benefits 
to using NaCNBH3 are the increased pH range (pH 7.0 – 9.0) and a higher degree of lysine 
modification.  Another difference between the methods is that Jentoft and Dearborn used carbon-
13 NMR (13C-NMR) to study the dimethylamino peaks instead of 1H-NMR.  Reductive 
methylation of the lysyl side-chains can yield monomethylamines and dimethylamines depending 
on the efficiency of the reaction and limiting reagents.  The 1H chemical shifts of both mono- and 
dimethyl peaks are similar and often overlap each other as well as other 1H signals from the protein.  
Titration (pH) experiments are often used to differentiate the - and -dimethylamino peaks, 
however significant 1H signal overlap due to an inefficient reaction can render this method 
ineffective as signals shift in the same direction with pH.  On the other hand, the 13C chemical 
shifts of methylamines are sensitive to the “amine order.”  Monomethylamines (32 – 34) and 
dimethylamines (41 – 44) are isolated from each other as well as other signals from the protein.  
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Jentoft and Dearborn demonstrated that -dimethylamino peaks shift upfield while the -
dimethylamino peaks shift downfield with increasing pH.  Using this new method of reductive 
methylation and 13C NMR, Jentoft et al. studied RNase-A.  Peak assignments of RNase-A were 
made by comparing the 13C-spectra of dimethylated RNase-A to the spectra of model compounds 
and verified both the -dimethylamino and Lys41 -dimethylamino peaks by pH titrations.  This 
work demonstrated the benefits of using the 13C NMR peaks and became the basis for ensuing 
experiments. 
Variations of Jentoft and Dearborn’s method were later used by Gerken et al. to study 
lysozyme and Sparks et al. to study apolipoprotein A-1 (apoA-1).118-120  Instead of using model 
compounds to verify assignments made from experimental pKa values, Gerken et al. used the x-
ray structure of lysozyme, while Sparks et al. used the predicted secondary structure of apoA-1 to 
make and verify assignments.  Like their predecessors, each of the methods is limited by the 
number of distinct pKa values.  Additionally, altered methods used by Gerken et al. and Sparks et 
al. are limited by their reliance on determined and predicted structural data, respectively.  Using 
pH titrations for assigning dimethylamino peaks is proven to be a useful tool; however, 
supplementing with a secondary technique is necessary to achieve absolute assignment.  In order 
to use reductive methylation as a strategy to study protein structure by NMR, it is important that 
the assignment techniques not rely on prior knowledge of the protein other than the amino acid 
sequence. 
 In 1988, Dick et al. used a 13C-NMR, pH titration method on fd gene 5 protein (G5P) with 
peptide sequencing of partially radiolabeled (3H and 14C) G5P to make assignments.94  This method 
advanced the development of an ideal assignment strategy and was the first to utilize partial 
methylation for assignment.  In this method, G5P was reductively 13C-methylated both free 
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(control) and bound to a ligand followed by subsequent 14C-methylation to completion (unbound) 
to incorporate radiolabels.  The protein was enzymatically digested and sequenced by Edman 
degradation.  Radioactivity was monitored during degradation to assess the level of protection by 
bound ligand of each lysyl residue.  Those lysyl residues with higher radioactivity exhibited lower 
peak intensity in the 13C-NMR spectrum.  One of the lysines of G5P is the C-terminal residue, 
which Dick et al. cleaved using carboxypeptidase B.  Subsequent difference spectra of methylated 
G5P and the carboxypeptidase-modified G5P were used to assign the C-terminal lysyl residue.  
Degenerate levels of radioactive isotopes led to group-wise assignments; however, absolute 
assignments were possible by comparing the data to the x-ray crystal structure. 
 The assignment of dimethylamino NMR peaks soon progressed with the introduction of 
two dimensional (2D) NMR.  The 2D experiments improved the resolution of the dimethylamino 
peaks by combining the resolution and chemical shift dispersion of dimethylamino peaks in the 
13C-dimension with the separation of the peaks in the 1H-dimension and sensitivity of 1H detection.  
Zhang and Vogel used site-directed mutagenesis to assign dimethylamino peaks in a 1H-13C 
heteronuclear multiple quantum coherence (HMQC) spectrum of reductively methylated 
mammalian calmodulin (CaM).121  Individual mutants (Lys → Gln) of CaM were generated for 
each of the 7 lysl residues followed by reductive methylation with 13C-formaldehyde.  Each peak 
was assigned by its absence in the spectrum of the corresponding mutant.  This assignment method 
is the first to achieve absolute assignment without prior knowledge of the target protein’s structure 
and has significant implications towards protein structural studies.  Although technically sound 




 In 2000, Ashfield et al. presented an assignment method that utilized matrix assisted laser 
desorption ionization – time of flight (MALDI-TOF) MS to identify partially 13C-methylated 
lysines on tryptic peptides.122  The use of MS to probe the extent of methylation at each lysine is 
an alternative to peptide sequencing (Edman degradation) used by Dick et al. and does not require 
radio-labeling.  Dimethylamino NMR peaks of  human MIP-1α D26A (hMIP-1), which contains 
3 lysines, were assigned by correlation of the disappearance of unmodified peptide masses 
observed in MS with the appearance of mono- and dimethylamino peaks seen in 13C 1-D and 2D 
1H-13C heteronuclear single quantum coherence (HSQC) NMR spectra.  Reductive methylation of 
hMIP-1 under conditions in which the protein forms a dimer revealed that one of the lysyl 
residues was completely protected from modification.  The authors were able to make absolute 
assignments of the 3 reductively methylated lysines of hMIP-1with only the amino acid 
sequence as prior knowledge.  
The MS-assisted assignment method, developed by Macnaughtan et al., expands on the 
Ashfield method with the introduction of using MS to measure the amount of 13C incorporated at 
each dimethylamine.123  This method utilized partial labeling for assignment based on the varying 
rates of the reductive methylation reaction at each site.  Partial labeling with 13C-formaldehyde 
followed by labeling with excess natural abundance formaldehyde resulted in varying levels of 13C 
at each dimethylamine.  The amount of 13C-incorporation at each site was measured by NMR using 
the peak volumes in a 2D 1H-13C HSQC spectrum and MS using the shift in the isotopic profile of 
peptides produced by trypsin digestion.  MS also provides the identity of the dimethylamine 
through the unique mass-to-charge (m/z) of the peptide, which can also be verified by tandem MS 
experiments.  By correlating the NMR and MS data for 13C-incorporation, the dimethylamino 
peaks can be assigned knowing only the amino acid sequence of the target protein.  Assignments 
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of the dimethylamino NMR peaks of hen egg white lysozyme were made through the correlation 
of 13C-incorporation percent values calculated for both tryptic peptides with MS and NMR peaks 
of 2D 1H-13C HSQC NMR experiments.  While the range of partial labeling was good (30.2 – 71.4 
%), the accuracy of the NMR and/or MS measurements of 13C-incorporation did not allow for 
complete assignment.  In addition, the MS data was incomplete because individual isotopic profile 
measurements could not be made for the two N-terminal dimethylamines or for the tandem lysines, 
Lys96 and Lys97.  The inherent difficulty in assigning the N-terminal lysine led to the 
supplemental method presented by Roberson et al.124  This method presented two techniques to 
identify and assign the N-terminal lysine - and -dimethylamino NMR peaks.  The first method 
used aminopeptidase to identify the two peaks belonging to the N-terminal lysine, and the second 
method used pH-induced chemoselectivity to modify either the -amine or the lysine side-chain 
-amines.  Assignments were made by the loss of peaks in 2D 1H-13C HSQC spectra and by using 
the MS-assisted assignment method on selectively labeled samples.  The pH technique provides 
advantages over the titration approach in assigning the -dimethylamino peak because it does not 
require a supplemental technique or structural knowledge to confirm the assignments.  It also has 
the added benefit of assigning the N-terminal -dimethyllysyl peak, which has a pKa similar to 
other -dimethyllysines.  Establishment of these methods to supplement the original work by 
Macnaughtan et al. aided in further assignments of lysozyme; however, limited accuracy and 
degenerate labeling did not allow for absolute assignments, despite intense efforts to vary the 
extent of labeling.125 
 Recently, Larda et al. published a new approach for the assignment of -methyllysyl peaks 
for protein structural studies.69  Instead of focusing on dimethylamines, the authors presented a 
protocol that favors monomethylation of the amino groups to take advantage of the improved 
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resolution and overcome exchange broadening.  In addition, deuterium tags allowed the use of 
pulse sequences that filter out natural abundance 13C signals.  Assignments of methylamino peaks 
were made by comparing aromatic nuclear Overhauser effects (NOEs) and line broadening effects 
from dissolved nitroxide spin labels to that of predicted effects from the x-ray crystal structure.  
Dependence on the assignments made by Macnaughtan et al. and the crystal structure limits this 
method, although absolute assignments were achieved. 
1.3.5 Assignment of Reductively Methylated HEWL 
Lysozyme has been the model protein most often used in developing an assignment strategy for 
dimethyllysyl NMR peaks.  With six lysines and the N-terminal amine, seven sites of methylation 
are possible and will be referred to as Lys1, Lys1, Lys13, Lys33, Lys96, Lys97, and Lys116.  
Depending on the pH, ionic strength, and temperature of the reductively methylated lysozyme 
sample, the methyl groups of a single dimethylamine can be equivalent and exhibit one NMR peak 
or they can be non-equivalent and exhibit two NMR peaks.  The number of peaks and the peak 
widths depend on the dynamics associated with the methyl groups, such as bond rotations, amine-
inversion, and pKa.  Assigning the NMR peaks of the dimethylamino groups to the lysines and N-
terminal amine is usually performed within the pH range of 8 – 9 at room temperature, when each 
site has equivalent methyl groups and seven peaks are observed as shown in Figure 1.8.  
Assignments of the dimethylamino peaks have been made in part or in absolution by five of the 
methods discussed, which we refer to as Bradbury, Gerken, Macnaughtan, Roberson, and Larda 
(Table 1.2).  Each assignment method will be discussed in detail and their results compared. 
In the first study, conducted by Bradbury and Brown, six resolved peaks corresponding to 
the six -dimethyllysines were titrated to obtain pKa values and then assigned using selective 
broadening effects with increasing concentrations of Gd3+.115  This method is based on the 
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Table 1.2.  Assignments of dimethylamino NMR peaks to the lysyl residue number and N-terminal 
amine of reductively methylated hen egg white lysozyme with peak numbers corresponding to 






a Data from reference 115. 
b Data from reference 119. 
c Data from reference 123. 
d Based on data from reference 124 and 123. 
e Data from reference 69. 
 
assumption that the paramagnetic ion binds in a single location between Glu35 and Asp52.  Each 
residue was assigned based on the observed pKa values compared to those of model compounds 
and the side-chain interactions interpreted from the x-ray crystal structure.  The authors noted that 
the only ambiguity in the assignments was between peaks 1 and 2, corresponding to Lys97 and 
Lys96, respectively, citing identical chemical shifts at pH 4.5.  Paramagnetic perturbation studies 
have been useful in protein structure determination; however, when used to assign NMR peaks, 
this technique requires structural knowledge of the protein.  For that reason this method is not 
applicable to proteins whose structures have not been solved.  In addition, the assumption made in 
this assignment strategy was questioned by Gerken et al., citing multiple binding sites for Gd3+ at 
high concentrations.119 
Gerken et al. used observed pKa values and chemical shifts to make assignments of 
lysozyme dimethylamino NMR peaks.119  The αLys1 peak was assigned by the distinct pKa and 
chemical shift.  A suggested “salt bridge” between Lys13 and the C-terminal Leu129 in the x-ray 
crystal structure aided in the assignment of Lys13’s dimethylamino peak.  This assignment was 
Peak number Bradburya  Gerkenb Macnaughtanc Robersond Lardae 
1 97 ~97 1 or 13 13 13 
2 96  33 or 116 33 or 116 116 
3 116 13 1 or 13 97 96 
4 13 ~97 1 96 97 
5 33  33 or 116 33 or 116 33 
6 1 1 96 1 1 
7 1 1 97 1 1 
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confirmed with the altered pKa value of Lys13 when Leu129 was cleaved.  Likewise, the Lys1 
was assigned with assistance from the suggested ion pairing between Lys1 and Glu7.  Lys97 was 
deduced to be either peak 1 or 4 (peak numbering based on Figure 1.8 and not on Gerken et al.), 
however, the remaining peaks could not be unambiguously assigned.  Table 1.2 summarizes the 
peak assignments for each method for direct comparison.  Gerken’s assignments agree with 
Bradbury’s for Lys1, Lys1, and Lys97 (peak 1), but other assignments were different or missing.  
Like Bradbury and Brown’s method, this method is limited to those proteins whose 3D structures 
have been solved.  Even though both methods used suggested salt bridges and ion pairings from 
the crystal structure to justify their assignments, the assignments of all, except for Lys1 and 
Lys1, conflict.  Viable arguments were presented to rationalize the assignments from both 
 
Figure 1.8.  1H-13C HSQC of 13C-dimethylated HEWL (120 M) at pH 8.1 on a 600 MHz 
spectrometer in approximately 5 min. with the same numbering scheme of Table 1.2.  Reproduced 
from (Macnaughtan, M. A.; Kane, A. M.; Prestegard, J. H., Mass spectrometry assisted assignment 
of nmr resonances in reductively c-13-methylated proteins. J Am Chem Soc 2005, 127, 17626-
17627.) with permission of the publisher. 
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methods, which suggests that reliance on the crystal structure introduces bias when assigning the 
NMR peaks.   
 Assignments of lysozyme dimethylamino NMR peaks by Macnaughtan et al. relied on the 
correlation of isotope incorporation measurements using NMR of the intact protein and MS of 
dimethylamino, tryptic peptides.123  Definitive assignments were made for three of the seven peaks 
(Lys1, Lys96, and Lys97), but the remaining four peaks were assigned pairwise (Lys1 and 
Lys13; Lys33 and Lys116) as shown in Table 1.2.  Absolute assignment of all dimethylamino 
peaks were prohibited by two problems associated with this method.  First, isotope incorporation 
was degenerate for two pairs of sites.  The reaction rates at these sites are comparable, likely due 
to similar microenvironments.  Various methods have been tested to break the degeneracy, 
including varying the reducing agent and using 18-crown-6-ether as a selective protecting agent.124  
Improving the accuracy of the NMR and/or MS measurements may reveal a difference in the level 
of labeling.  The second problem is that individual isotope incorporation values could not be 
measured for all dimethylamines with MS.  For peptides that contain two dimethylamines, only 
the average isotope incorporation can be measured with MS.  There are a couple of instances in 
which this can happen: (1) if a peptide contains more than one lysine and (2) if the N-terminal 
residue of the protein is a lysine.  Trypsin is commonly used to digest proteins for MS analysis, 
but it does not cleave at dimethylated lysines.  Consecutive lysines, such as Lys96 and Lys97 in 
lysozyme, pose a significant challenge for digestion.  One possible solution is to use high-
resolution tandem MS to measure the isotopic profile of peptide fragments.  On the other hand, the 
selectivity of trypsin can be an advantage.  The assignments of Lys96 and Lys97 are based on the 
observation of peptide Lys97-Arg112 in the MS, which suggests that some Lys96 was not 
methylated, even under conditions of excess formaldehyde.  Consequently, the NMR peak with 
46 
 
the lowest peak area (peak 6) was assigned to Lys96 (Table 1.2).  The - and -dimethylamines of 
the N-terminal lysine cannot be separated using a protease and other methods must be used.  
Roberson et al. published two methods to distinguish, identify, and assign both the αLys1 
and εLys1 NMR peaks as a supplement to the MS-assisted assignment method.124  The NMR 
spectrum of lysozyme treated with aminopeptidase displayed the disappearance of peaks 6 and 7, 
identifying these peaks as the dimethylamino groups of the N-terminal lysine.  Further 
investigation of the peaks with pH-induced selectivity of the reductive methylation reaction 
confirmed those results.  At low pH, the α-amine methylated at a higher rate than any of the side-
chain ε-amines, but at high pH, no methylation was observed for the α-amine.  The high pH sample 
made it possible to distinguish the αLys1 peak from the εLys1 peak.  With little to no methylation 
at the -amine, the N-terminal peptide could be analyzed with MS to give a 13C-incorporation 
value for the ε-dimethylamine, which made the assignment of εLys1 possible (independent of the 
aminopeptidase method).  Although peaks 6 and 7 were previously assigned to Lys96 and Lys97, 
respectively, data from the N-terminal methods were conclusive and these peaks are εLys1 and 
Lys1, respectively.  Combining these new assignments with Macnaughtan’s data123 provides new 
assignments for peaks 1 (Lys13), 3 (Lys97), and 4 (Lys96), but peaks 2 and 5 are still ambiguous 
(Lys33 or Lys116) due to degenerate labeling (Table 1.2).  The assignment of Lys1 and Lys1 
may provide insight to improve the MS-assisted assignment method.  The average 13C-
incorporation measurements of Lys1 and Lys1 are 54.2% by NMR (Peak 6 = 30.2%, Peak 7 = 
78.3%) and 44.8% by MS (peptide K1-R5).  The difference between the values is very large and 
clearly indicates that the accuracy of the NMR and/or MS measurement must be improved for the 
method to be viable. 
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Larda et al. introduced the use of monomethylamines and deuterium-filtered NMR to 
improve the quality of the NMR peaks for assignment.69  Using data from Macnaughtan et al. and 
predicted, spin-label-induced line broadening from the x-ray crystal structure, all monomethyl- 
and dimethylamino signals were assigned (Table 1.2).  The assignment method is limited by its 
reliance on the crystal structure, the same as the Bradbury and Gerken methods.  The adjusted 
assignments made by combining Roberson and Macnaughtan’s data agree with Larda’s 
assignments, with the exception of Lys96 and Lys97.  It is not surprising that the assignments of 
Lys96 and Lys97 are unresolved, since a pair of consecutive lysines is difficult to distinguish using 
spin-labels or MS.        
 To date, the only consensus and conclusive assignments of dimethylamino peaks of hen 
egg white lysozyme are the Lys1 and the Lys1.  Although there is some overlap in the 
assignment of the remaining peaks, they are difficult to accept as definite.  The use of crystal 
structures to aid in the assignments produces conflicting results and limits the applicability of the 
method.  While proteomics MS is useful, it is not without its limitations, including the need to 
separate, identify, and measure every dimethylamine.  Advanced tandem MS methods and more 
accurate modeling of dimethylated lysines from crystal structures may alleviate the current 
challenges to dimethylamino NMR peak assignment. 
To date, the only consensus and conclusive assignments of N-dimethylamino resonances 
of hen egg white lysozyme are the -amine and the K1 -amine.  Although there is some overlap 
in the assignment of the remaining resonances, not enough evidence has been presented to make 
definite assignments.  Each of the methods presented here has its limitations and limited reliability.  





In 40 years, labeling proteins with reductive methylation has proved useful to many 
analytical techniques and permitted the study of proteins with limited prior knowledge of structural 
properties.  Using isotopically labeled reagents, radio- or magnetic-isotopes can be incorporated 
in high yield and with little impact on the protein’s overall fold or activity.  Labeling a protein with 
13C-dimethylamino groups provides a means of studying proteins by NMR and is particularly 
useful for labeling proteins from source or purified from eukaryotic cell cultures.  The 13C-
dimethylamino NMR peaks can be studied in a number of ways to characterize the protein’s 
activity and probe its tertiary and quaternary structures.  The applicability of the reductive 
methylation strategy to NMR is limited by the lack of a universal assignment strategy that does 
not require a high resolution structure or recombinant expression.  Our review of five assignment 
strategies for reductively 13C-methylated hen egg white lysozyme exemplifies the difficulty of the 
task and creativity devoted to overcoming this hurdle.  Using partial labeling of the protein (radio- 
or magnetic-isotopes) and a secondary method to identify and correlate the data (Edman 
degradation/scintillation or MS) has the advantage of not requiring a protein structure for 
assignment.  Such an assignment strategy has the potential to be universal, but requires higher 
accuracy in measuring the amount of partial labeling for absolute correlation.  When the structure 
of a protein is available, soluble (nitroxide) or bound (Gd3+) spin-labels and measured pKa values 
can be used to make assignments.  This strategy produced conflicting results for hen egg white 
lysozyme, but improved computational modeling of reductively methylated proteins may provide 
more accurate predictions of paramagnetic effects and the state of salt bridges in solution. 
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CHAPTER 2 ATTEMPTS TOWARD UNAMBIGUOUSLY ASSIGNING 13C-
DIMETHYLAMINE NMR RESONANCES1 
2.1 Introduction 
As a tool for protein structure and dynamics studies, nuclear magnetic resonance 
spectroscopy typically requires stable magnetic isotope enrichment to improve signal intensity and 
allow assignment.1  Complete isotopic labeling is most commonly achieved through 
overexpression in Escherichia coli with 15N-ammonium chloride and 13C-glucose.2-3  Because 
many human proteins require eukaryotic hosts for proper folding and post-translational 
modifications, metabolic labeling is not always viable.  An alternative approach is sparse isotopic 
labeling using protein-chemical modification with highly selective reactions for specific amino 
acids.4   13C-methyl tagging via reductive methylation has been successful in both NMR and X-
ray crystallographic protein studies.  Under non-denaturing conditions, the N-terminal α-NH2 and 
the lysine side chain ε-NH2 groups are selectively methylated in the presence of formaldehyde and 
a reducing agent (Scheme 2.1).  The reaction produces dimethylamino groups because the 
monomethylamine readily reacts due to a higher pKa than the non-methylated primary amine.
5-6  
By using 13C-formaldehyde, 13C-labels are incorporated into the protein in the form of 13C-
methyls.7  Once incorporated, protein structure and dynamics are usually not perturbed.8 The 13C-
methyls can be used as probes in NMR experiments to study protein-protein interactions and as 
sites to collect distance constraints using paramagnetic perturbations.9-10  
 
                                                 
1 This chapter previously appeared as Roberson, K. J.; Macnaughtan, M. A., Attempts towards 
unambiguously assigning 13C-dimethylamine NMR resonances. All Results J.: Chem. 2013, 4, 






Scheme 2.1.  The reductive methylation reaction: In the presence of formaldehyde and a 
reducing agent, the primary amine is reductively methylated to produce monomethylamine.  In 
the presence of excess formaldehyde, the monomethylamine undergoes a second reductive 
methylation to produce dimethylamine. 
Since its introduction as a means for protein modification by Means and Feeney in 1968,5 
reductive methylation has been used to incorporate probes of structural and dynamic properties.9-
16  When the 13C-methyl groups are used to study proteins with NMR, the utility of the labeling 
method is limited by difficulties in assigning the 13C-methyl resonances with their corresponding 
lysine residues.  Past assignment approaches have relied on a small number of methylation 
sites,14,17 known structural properties,7,11,15,18-20 or genetic modifications.21  One strategies used 
matrix-assisted laser desorption ionization (MALDI) mass spectrometry (MS) to identify partially-
methylated lysines of tryptic peptides of human MIP-1α by correlating the disappearance of 
unmodified peptide masses in MS with the appearance of mono- and dimethylamine signals in 2D 
1H-13C HSQC-NOESY NMR spectra.17  In 2005, we presented an improved method for assigning 
dimethylamine resonances in 2D 1H-13C HSQC NMR spectra that requires no prior knowledge of 
the protein except the amino acid sequence.22  The mass spectrometry-assisted assignment method 
uses isotopic ratio measurements.  Using limiting 13C-formaldehye, this technique takes advantage 





distinguish sites in NMR and MS data.  Data presented on this procedure using lysozyme showed 
two inherent problems with the strategy: 1) degenerate levels of 13C-incorporation and 2) no MS 
method to independently measure the 13C-incorporation of the - and -dimethylamines on Lys1.22 
To overcome the degeneracy in labeling lysozyme with the reductive methylation reaction, 
we investigated two methods: 1) reductive methylation in the presence of 18-crown-6-ether (18C6) 
and 2) reductive methylation using multiple reducing agents.  To assign the - and -
dimethylamine resonances of the N-terminal lysine residue of lysozyme, we explored a non-
destructive Edman degradation method. 
2.2 Experimental  
2.2.1 Reductive methylation in the presence of 18C6 
Lysozyme was reductively methylated to produce two samples: (1) a fully 13C-labeled 
sample and (2) a partially 13C-labeled sample.  The fully labeled sample is a control sample and 
percent 13C-incorporation calculated for the partially labeled sample is normalized to the fully 
labeled sample.  After the partially labeled sample is modified with 13C-formaldehyde, it was set 
to undergo another reductive methylation with natural abundance 12C-formaldehyde to produce a 
fully dimethylated protein sample, which make interpreting the NMR spectrum easier. 
2.2.2 Fully 13C-labeled control sample 
To an aqueous solution of lysozyme (2.5 mg, 5 mg/mL), DMAB (6.13 µL, 1 M) was added, 
followed by 13C-formaldehyde (12.25 µL, 1 M).  The reaction mixture was shaken at 4 °C for 2 
hours.  A second aliquot of DMAB and 13C-formaldehyde was added, and the mixture was shaken 
at 4 °C for an additional 2 hours.  DMAB (3.06 µL, 1 M) was added, and the mixture was shaken 





2.2.3 Partial 13C-labeling 
To an aqueous solution of lysozyme (5 mg/mL), an aliquot of 18C6 (0.66 mg, 5 µmol or 
1.32 mg, 10 µmol) was added for final concentrations of 5 and 10 mM respectively, followed by 
DMAB (1.53 µL, 1 M), then 13C-formaldehyde (3.06 µL, 1 M).  The mixture was shaken at 4 °C 
for 2 hours.  A second aliquot of DMAB and 13C-formaldehyde were added, and the mixture was 
shaken at 4 °C for an additional 2 hours.  DMAB (0.77 µL, 1 M) was then added, and the mixture 
was shaken at 4 °C overnight for a total of 24 hours. 
For reactions at ratios 2:3 and 2:5, an aliquot of 18C6 (4.0 mg, 15 µmol or 6.6 mg, 25 
µmol) was added for final concentrations of 30 and 50 mM, respectively. 
2.2.4  Excess natural abundance formaldehyde to complete methylation 
To an aqueous solution of lysozyme (5 mg/mL), DMAB (6.13 µL of 1 M) was added, 
followed by formaldehyde (12.25 µL of 1 M).  The mixture was shaken at 4 °C for 2 hours.  A 
second aliquot of DMAB and formaldehyde were added, and the mixture was shaken at 4 °C for 
an additional 2 hours.  DMAB (3.06 µL, 1 M) was then added, and mixture was shaken at 4 °C 
overnight for a total of 24 hours. 
2.2.5  Reductive methylation using multiple reducing agents 
The procedures for fully and partially 13C-labeling and excess natural abundance 
formaldehyde described above were used without 18C6 and with various reducing agents.  One 
fully 13C-labeled control sample with DMAB and partially 13C-labeled samples with each reducing 
agent were prepared.  All reducing agent aliquots were from 1 M stock solutions except sodium 





2.2.6 Preparation for NMR 
The protein samples were exchanged into a D2O, 50 mM sodium borate buffer at pH 8.5 
using a 4mL centrifugal filter with a 3kDa molecular weight cutoff. 
2.2.7 NMR 
All 1D 1H - 13C heteronuclear single-quantum coherence (HSQC) NMR spectra were 
collected using a 700 MHz Varian spectrometer equipped with a 5 mm-HCN-5922 probe.  1,2-
dichloroethane-13C2 (26 mM in D2O) was used as an external reference via coaxial insert.  The 
protein concentrations were 50 M. Experiments were acquired at 25 °C.  All experiments were 
acquired using a relaxation delay of 5s, 256 scans, and a 4529Hz spectral width.  The total 
acquisition time for each experiment was approximately 25 minutes.  1,2-dichloroethane-13C2 was 
used as a chemical shift reference instead of the traditional DSS.  The 1D 1H-NMR of the PITC-
lysozyme was acquired using a relaxation delay of 1.5 s, 4 scans, and a 7022.5 spectral width.  The 
spectra were referenced to DSS.  
2.2.8 13C percent incorporation calculation from NMR data 
1D 1H-13C HSQC was performed on a fully 13C-dimethylated (control) protein sample.  
The area under each dimethylamine peak in the spectrum was integrated and set to 100% 13C-
incorporation for each site.  The areas of the corresponding peaks in the spectra for the partially 
13C-dimethylated samples were integrated.  13C percent incorporation of the dimethylamine peaks 
of the partially 13C-methylated samples was calculated as a fraction of the respective peak for the 





2.2.9 Non-destructive Edman degradation 
2.2.9.1 Coupling 
Lysozyme (10 mg, 0.680 µmol) was dissolved in pyridine, triethylamine, and water 
(1.2:15:10) co-solvent.  PITC (1.3 mg, 9.55 µmol) was added, and the reaction was stirred at 50 
°C for 30 minutes. 
2.2.9.2 Cleavage  
(1): PTH-lysozyme was dissolved in 100% TFA or concentrated HCl and stirred for 30 
minutes at room temperature. 
(2): PTH-lysozyme was dissolved in an organic solvent.  TFA was added to make a 75 % 
solution and stirred for 30 minutes at room temperature. 
(3): PTH-lysozyme was dissolved in triethylamine, acetic acid, and acetonitrile (7.5:3:5) and 
stirred at 50 °C for 30 minutes. 
2.3 Results and Discussion  
2.3.1 Reductive Methylation in the Presence of 18-Crown-6-Ether 
18C6 is known for its ability to form non-covalent complexes to metal cations and 
protonated primary amines in both solution and gas phase,23 hence its extensive use in peptide 
synthesis23-26 and purification.27-30  The 18C6 and protonated primary amine complex forms 
through a combination of three hydrogen bonds and ion-dipole interactions.  It is through this 
chemistry we postulated the concept shown in Scheme 2.2 to break the degenerate levels of 13C-
incorporation for reductively methylated lysozyme.  In solution, the lysine side chain amine exists 






Scheme 2.2.  Reductive methylation in the presence of 18C6. 
complexes with the protonated form, which is not the reactive species, and should hinder 
methylation at the site.  Binding affinities of 18C6 should be slightly different at each site based 
on steric accessibility and influences from surrounding residues, altering the relative reductive 
methylation rates. 
Initial methylation attempts in the presence of 18C6 were performed by varying the ratio 
of reactive amine concentration to 18C6.  Results showed that the competitive binding of the 
buffer-counter ion inhibited binding of 18C6 to the reactive amine.  Potassium ion binds better to 
18C6 than the sodium ion, which binds slightly better than the ammonium ion, while the lithium 
ion does not bind as well.31-32  For this reason, the potassium buffer was avoided and the sodium 
and lithium buffers were tested.  Lysozyme was reductively methylated in the presence of a sodium 
phosphate buffer (20 mM Na+) at ratios of 2:1 and 1:1 (moles of Na+: moles of 18C6).  In each 
experiment, lysozyme was reacted in the presence of 18C6 at pH 7.5. 
As shown in Figure 2.1, 18C6 had no effect on the methylation of lysozyme at these molar 
ratios, presumably because of the poor fit of the protein ammonium ion in the 18C6 cavity or the 
stronger binding of 18C6 to the sodium ions.  Both possibilities were tested by methylating 





counter ion is either sodium or lithium (Figure 2.1).  In each of these reactions, lysozyme was 
reacted in the presence of 18C6 at pH 7.5.  When in excess of the counter ion, 18C6 hinders 
reductive methylation of lysozyme; however, the effect is equivalent across each reactive site and 
did not solve the degenerate labeling problem, indicating that the affinity of the protein ammonium 
ions for 18C6 are not significantly different.  Switching the counter ion from sodium to lithium 
showed no significant differences in methylation, indicating that excess 18C6 is more important 
than counter-ion selection. 
  
Figure 2.1.  (Left)  Normalized NMR 13C percent incorporation of each reaction site of partially-
labeled lysozyme at 1:5 ratio (moles of reactive amine: moles of formaldehyde) in the presence of 
18C6 and sodium ion.  (Right)  Normalized NMR 13C percent incorporation of each reaction site 
of partially-labeled lysozyme at 1:5 ratio (reactive amine: formaldehyde) in the presence of excess 





2.3.2 Reductive Methylation Using Multiple Reducing Agents 
 In 1995, Means and Feeney reviewed the reductive methylation reaction and its efficiency 
as it related to different reducing agents.33  The strength of the reducing agent was found to be 
inversely related to the efficiency of methylation.  Here, we attempted to take advantage of the 
inefficiency of the stronger reducing agents, hypothesizing that the kinetic mode of action will be 
determined by the physical properties of the reducing agent and reactive site.  For instance, a 
reducing agent with a hydrophobic structure, like pyridine borane, would likely reduce a Schiff 
base in a hydrophobic pocket faster than a hydrophilic reducing agent and, in turn, break the 
degeneracy in the 13C-incorporation across the reactive sites.  Figure 2.2 a-e are structural 
representations of the hydrophobic regions of lysozyme (yellow) with each lysine residue (orange) 
labeled.  Reducing agents used in these experiments, in order of increasing strength, were 
dimethylamine borane complex (DMAB), pyridine borane complex, and sodium borohydride 
(Figure 2.2f). 
 
Figure 2.2.  (a-e)  Using the crystal structure of reductively methylated lysozyme by Rypniewski, 
et. al (PDB ID: 132L),8 the dimethylamino groups (orange) and hydrophobic residues (yellow) are 






Figure 2.3.  13C percent incorporation of partially 13C- reductively methylated lysozyme with 
different reducing agents normalized to fully 13C-methylated lysozyme with DMAB. 
Lysozyme was reductively methylated with a sub-stoichiometric amount of 13C-
formaldehyde in the presence of each reducing agent for partial labeling, and then methylated with  
excess natural abundance formaldehyde in the presence of dimethylamine borane complex to 





(data shown for 4°C).  Changing the reducing agent had no significant effect on the degenerate 
labeling between peaks A and D, as shown in Figure 2.3.  While the different reducing agents 
produced slightly different levels of 13C, most of the rates were degenerate within error.  
Interestingly, peaks D and F were reductively methylated at a faster rate with the small, 
hydrophobic DMAB than the hydrophilic NaBH4.  Previous studies have assigned Peak D as 
K9719,34 and peak F as the N-terminal α-NH2,
19,34-36 which were found to be sandwiched between 
hydrophobic regions (Figure 2.2).  These findings confirm our hypothesis that the hydrophobic 
DMAB would reduce a Schiff base in a hydrophobic region faster than a more hydrophilic 
reducing agent. 
2.3.3 Non-destructive Edman Degradation 
Since its introduction in 1950, Edman degradation has been used to determine the amino 
acid sequence of proteins until recent advances in mass spectrometry.37-38  Phenylisothiocyanate 
(PITC) is reacted with the N-terminal amine under mildly alkaline conditions to form a cyclical 
phenylthiocarbamoyl derivative.  When treated with acid, the derivatized terminal amino acid is 
cleaved.  After extraction, it is further treated with acid to form the more stable 
phenylthiohydantoin (PTH)-amino acid derivative.  During this process, the protein is sequentially 
cleaved to determine the amino acid sequence.  For our purpose, we were not necessarily interested 
in the cleaved PTH-amino acid derivative, but rather the remaining protein for structural studies; 
therefore it was important that the truncated protein remain folded.  Our plan was to use Edman 
degradation to remove the N-terminal lysine residue of lysozyme (Lys1) to assign the NMR peaks 
belonging to the -, and - dimethylamine of Lys1.  Upon NMR analysis, the Lys1 ε- 
dimethylamine peak will be absent and a new N-terminal α-dimethylamine resonance will be 





PITC was coupled to the N-terminus of lysozyme, the sample was freeze-dried, 
reconstituted, and analyzed with 1H NMR to verify the tertiary structure.  The broad range of 
resonances in the 1H NMR spectrum (not shown) confirmed that the PTH-protein was folded.  
Difficulty followed in attempts to cleave the derivatized amino acid from the protein.  Initially, 
lysozyme was dissolved in pure trifluoroacetic acid (TFA) or HCl for cleavage.  The acid was then 
exchanged for acetonitrile before the buffer was exchanged to phosphate to prevent further 
degradation of the protein by acid hydrolysis, since cleavage is sensitive to aqueous conditions.  
NMR analysis showed that the protein was unfolded and prompted another approach to preserve 
the protein’s tertiary structure. 
 Since lysozyme unfolded after cleaving with pure TFA and HCl, we investigated the use 
of other organic solvents in which lysozyme was soluble and not destructive to the protein 
structure.  In a study conducted by Chin et al., lysozyme was reported to be soluble in many organic 
solvents at concentrations greater than 10mg/mL.39  Here, we used methanol, dimethyl sulfoxide 
(DMSO), glycerol, and formamide as solvents for lysozyme before adding TFA (final 
concentration of 75%) for cleavage.  After cleavage, NMR studies showed that lysozyme unfolded 
in all solvents when treated with TFA.  Attempts to refold the protein were also unsuccessful.  In 
summary, all experiments performed under acidic conditions resulted in unfolded lysozyme.  We 
also attempted cleavage studies in basic conditions using a similar co-solvent system to that of the 
coupling reaction previously described by Barrett and Penglis.40  During the cleavage step at 75°C, 
the protein precipitated.  Precipitation was avoided when cleavage was performed at 50°C, but 
NMR showed the protein unfolded.  Moreover, cleavage studies were also unsuccessful using the 





(1.2:15:10).  To date, protein stability in association with the cleavage of the phenylthiocarbamoyl 
amino acid derivative has yet to be resolved. 
2.4 Conclusion 
Here we presented two theoretically sound methods to eradicate the degeneracy of 13C-
labeling via reductive methylation of lysozyme and one method to assign the - and -
dimethylamine of Lys1.  The reductive methylation of lysozyme in the presence of 18C6 was 
found to hinder the extent of methylation but was not selective.  Although a series of reducing 
agents were successful in reductively methylating lysozyme, they also did not produce the desired 
selectivity.  Non-destructive Edman degradation was promising, but unsuccessful in preserving 
the protein’s tertiary structure. 
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CHAPTER 3 METHOD TO IDENTIFY THE NMR RESONANCES OF THE 13C-
DIMETHYL N-TERMINAL LYSINE ON REDUCTIVELY METHYLATED 
PROTEINS2 
3.1   Introduction 
Nuclear magnetic resonance (NMR) spectroscopy is a valuable structural elucidation tool 
for proteins.1  NMR spectroscopy provides an in-solution, average snap shot of the protein in its 
native state.  To overcome the low natural abundance of stable magnetic isotopes, it is necessary 
to incorporate 13C and 15N into the protein of interest.  The most common method employed is 
recombinant expression in a bacterial host.2  One downside to bacterial host over-expression is it 
cannot produce post-translational modifications and does not work for all proteins.3  When 
bacterial expression is not a viable route for protein production, such as for glycosylated proteins 
and membrane proteins, over-expression in non-bacterial hosts can be used, but is difficult and 
expensive.  Alternative methods for incorporating 13C and 15N isotopes into proteins for NMR 
analysis include sparse labeling techniques using metabolic precursors for methyl labeling4 and 
single 13C, 15N amino acids5-7 in non-bacterial expression hosts.  A chemical approach to sparse 
labeling used herein is the well-established reductive 13C-methylation reaction (Scheme 3.1), 
where the primary amino groups on a protein—the N-terminal α-amine and the lysine, side chain 
ε-amines—react to form dimethylamines. 
 
Scheme 3.1.  Reductive methylation reaction 
 
                                                 
2 This Chapter previously appeared as (Roberson, K. J.; Brady, P. N.; Sweeney, M. M.; 
Macnaughtan, M. A., Methods to identify the NMR resonances of the 13C-dimethyl N-terminal 
amine on reductively methylated proteins. J. Vis. Exp. 2013,  (82) doi:10.3791/50875.). 






Reductive methylation was first introduced as a method to chemically modify proteins by 
Means and Feeney.8   The advantages of this reaction are it is applicable to any protein and works 
under mild conditions at buffered, physiological pH and low temperatures.  In the presence of 
formaldehyde and a reducing agent, such as dimethylamine borane complex (DMAB), the lysine 
ε-amino groups and the N-terminal α-amino group are selectively methylated to produce 
dimethylated amines.  
Reductive methylation has been successfully used with both NMR and X-ray 
crystallography.  Reductive methylation is used to facilitate the crystallization of otherwise 
intractable proteins.9 Hen egg white lysozyme was the first protein crystallized in the dimethylated 
form.  The root-mean square difference of the heavy atoms in the methylated and unmethylated 
lysozyme structures is 0.40 Å.10  This comparison demonstrates that the protein structure can be 
maintained after reductive methylation, making the reaction a viable, labeling tool for structure 
elucidation. 
By using 13C-labeled formaldehyde in the reductive methylation reaction, 13C-dimethylated 
amines are produced.  The 13C-dimethylamines are NMR-detectable probes that have been used to 
study protein dynamics and structure.11-16  Jentoft et al. used 13C-formaldehyde to reductively 
methylate ribonuclease A to study the dynamics, kinetics, and substrate binding of the dimethyl-
lysines using 13C NMR.12  Gerken et al. performed similar studies on lysozyme.17  
The reductive 13C-methylation labeling technique has always been limited by the lack of 
NMR signal assignment.15  Most assignment strategies have relied on small numbers of sites, 
known structural properties, or extensive genetic modifications.18-20  One assignment strategy 





employs site-directed mutagenesis, which is time consuming.18  The use of mass spectrometry 
(MS) to aid in the NMR assignment of reductively 13C-methylated amines was first reported by 
Fisher et al.  Matrix assisted laser desorption ionization time-of-flight (MALDI-TOF) MS was 
used to identify the lysines at the interface of a dimer.  The partially methylated lysines of human 
MIP-1α tryptic peptides were identified with MS and correlated with the appearance of mono- and 
dimethylamine signals of the intact protein observed in 2D 1H-13C NMR spectra.21  Our group 
expanded on the use of MS and presented an assignment method that requires no prior knowledge 
of the protein’s structure or properties other than the amino acid sequence.22  This method is 
applicable to most proteins except for proteins with an N-terminal lysine because the MS isotopic 
profile of the N-terminal lysine - and -13C-dimethylamines cannot be independently measured.   
To distinguish the - and -amino groups on proteins with capillary electrophoresis, 
Córdova et al. presented a method to selectively acetylate the N-terminal α-amine or side chain ε-
amine by controlling the reaction pH.23  The reaction selectively favored the N-terminal α-amine 
at low pH and the side chain ε-amines at high pH.  Similarly, Gerken et al. used low pH and a sub-
stoichiometric amount of 13C-formaldehyde to selectively methylate the α-amine of lysozyme and 
identify its resonance after denaturation.17   
Here we present one method to identify the N-terminal α-dimethylamine and the side chain 
ε-dimethylamine sites of an N-terminal lysine residue using pH.  Because this method maintains 
the structural integrity of the protein, the NMR assignments can be used for protein structure and 





3.2  Experimental 
3.2.1 Materials and Methods 
Lysozyme from hen egg white, borane-dimethylamine complex, formaldehyde (36.5% 
wt/wt), acetonitrile (HPLC grade), trifluoroacetic acid (99%), ammonium sulfate, ammonium 
bicarbonate, sodium borate, potassium phosphate, and sodium phosphate (monobasic and dibasic) 
were supplied from Sigma. 1,2-dichloroethane-13C2, 
13C-formaldehyde (99%) and deuterium oxide 
(99.9%, D2O) was supplied from Cambridge Isotope Laboratories.  Centrifugal filters (4mL with 
3K MWCO) were supplied from Fisher Scientific.  Sinipinic acid was supplied by Fluka.  
3.2.2 Reductive methylation Lysozyme (Generic Procedure) 
To an aqueous solution of buffered lysozyme (0.5 mL, 5 mg/mL) was added an aliquot of 
DMAB (1M) followed by an aliquot of 13C-formaldehyde (1M) twice the volume of the DMAB 
aliquot.  The amount of 13C-formaldehyde used for each sample will be given as the ratio of moles 
of reactive amine to moles of 13C-formaldehyde, referred to as ratio throughout.  The sample was 
shaken and incubated at 25 °C for an hour.  Aliquots of DMAB and 13C-formaldehyde were added 
again followed by an hour of shaking and incubation at 25 °C.  The sample was buffer-exchanged 
into sodium phosphate buffer at pH 7.5 to remove excess reagents and side products.  50 µg of the 
sample was set aside for MALDI analysis to calculate the percentage of 13C incorporation.  For all 
partially labeled samples, unless otherwise noted, the reaction was repeated with excess natural 
abundance formaldehyde at a ratio of 1:10 (1 mole of reactive amine: 10 moles of formaldehyde) 
to produce homogeneous, dimethylated protein.  The sample was buffer-exchanged into D2O 





3.2.2.1 Fully 13C-labeled Lysozyme 
The lysozyme sample was reacted in 50 mM sodium phosphate buffer at pH 7.5 at a ratio 
of 1:10. 
3.2.2.2 Partially 13C-labeled Lysozyme  
The lysozyme sample was reacted in 50 mM sodium phosphate buffer at pH 7.5 at a ratio 
of 1:5. 
For reactions at ratios 2:3 and 2:5, an aliquot of 18C6 (4.0 mg, 15µmol or 6.6mg, 25µmol) 
was added for final concentrations of 30 and 50mM, respectively. 
3.2.2.3 Partial 13C-methlation at Low pH 
Two lysozyme samples were reacted in 50 mM sodium phosphate buffer at pH 6.0 at a ratio 
of 1:5.  One was not methylated to completion with natural abundance formaldehyde.  
3.2.2.4 Partial 13C-methlation at High pH 
The lysozyme sample was reacted in 50 mM sodium borate buffer at pH 10.0 at a 1:5 ratio. 
3.2.3 MALDI-TOF Sample Preparation 
The high pH protein sample (50 µg), 15 µL of 5X ammonium bicarbonate buffer (500 
mM), and 2 µL of ultrapure water were added to a 0.5 mL microcentrifuge tube and incubated at 
60 °C for 60 minutes.  After cooling to room temperature, 2 µL of iodoacetamide was added and 
the sample was covered with foil and incubated at room temperature for 25 minutes.  Dithiothreitol 
(2 µL, 500 mM) was used to quench the reaction.  Trypsin (2 µg) was added and the sample was 
incubated at 37 °C for 18 – 24 hours.  The reaction was quenched with trifluoroacetic acid (1.5 





3.2.4 MALDI-TOF Analysis 
Data was acquired using a Bruker UltrafleXtreme MALDI-TOF-TOF instrument equipped 
with a Nd:YAG in linear mode, with 89-92% laser energy, and an average of 4 x 500 shots.  The 
spectra were smoothed using the Savitzky-Golay algorithm, the baseline was subtracted, and the 
apex peak was manually selected using the Bruker FlexAnalysis software. 
3.2.4.1  Determination of the Total Percent 13C percent Labeling by MALDI 
After the samples were reductively methylated with 13C-formaldehyde, the extent of 
modification was determined using MALDI-MS. The protein sample was co-spotted in equal parts 
on the MALDI target plate with unmodified lysozyme and the matrix, sinipinic acid.   
The percentage of 13C incorporation for the modified lysozyme sample (%13Cprotein) was 
determined using Equation 1: 




where M is the average m/z of the reductively 13C-methylated lysozyme sample, M0 is the average 
m/z of the unmodified lysozyme sample, and 210.4 is the theoretical mass shift corresponding to 
100% reductive 13C-methylation, i.e. all 7 primary amino groups labeled with 2 13C-methyl groups. 
3.2.5 Determination of the percent 13C labelling at each site: NMR 
Each peak in the 1D 1H-13C HSQC of each sample was fit using Equation 2 and Mathcad 
15.0 software (Parametric Technology Corporation).  Equation 2 is the sum of a Lorentzian and 
Gaussian line shape with six variables: baseline offset (b), peak amplitude (A), Lorentzian 
lineshape fraction (f), peak frequency (0), Lorentzian linewidth (wL), and the Gaussian linewidth 


















Using the best fit parameter for each peak, the peak areas were calculated and normalized to the 
total percent 13C incorporation using equation 3. 





where 𝐴𝑖 is the individual peak area and 𝐴𝑡𝑜𝑡𝑎𝑙 is the sum of all peak areas.  
The percentage of reductive 13C-methylation at each primary amino group (i) for the 
partially labeled lysozyme samples (%13Ci) was calculated by comparing the normalized NMR 
peak areas of a fully, labeled control sample (𝐴𝑖,𝑐𝑜𝑛𝑡𝑟𝑜𝑙
′ ) to the normalized NMR peaks areas of the 
partially labeled sample (𝐴𝑖
′) using Equation 4. 





3.2.6 Mass Spectrometry 
From the mass spectrum, a weighted average using the peak intensity and isotope number 
(where monoisotopic = 0) was calculated for each peptide (mavg). Additionally, theoretical 
isotopic distributions were generated using MS-Isotope (Protein Prospector, UCSF)24 for the 
same peptide sequence with natural abundance labeling and 99.9% 13C labeling; these were 
called the 12C and 13C standards, respectively.  Using the calculated mavg values for the standards, 
the %13C labeling was calculated using Equation 5. 
Equation 3.5: %13𝐶 = 100 − [(
𝑚𝑎𝑣𝑔−𝑚13𝐶
𝑚12𝐶−𝑚13𝐶





3.3 Results  
3.3.1 Reductive Methylation and pH 
The NMR spectra of the reductively 13C-methylated lysozyme samples at pH 6.0 (low), 
10.0 (high), and 7.5 (the optimum pH for the reducing agent, DMAB) are shown in Figure 3.1.  
For the pH 10.0 sample, the intensity of peaks 1 – 6 are nearly the same as the pH 7.5 sample, but 
peak 7 is missing (Figure 3.1c), indicating that the amino group corresponding to peak 7 was not 
modified with 13C-methyl groups.  The spectrum of the pH 6.0 sample (Figure 3.1a) shows no 
discernible preference for an amino group when compared to the pH 7.5 sample (Figure 3.1b). 
 
Figure 3.1.  1D HSQC NMR spectra obtained at 25°C and pH 8.5 of reductively 13C-methylated 





To better visualize the results of reductive 13C-methylation at pH 6.0, a second experiment 
with 7 moles of reactive amine to 2 moles of 13C-formaldehyde was performed without completing 
the methylation with natural abundance formaldehyde.  As shown in Figure 2, the NMR spectra 
of this sample show both mono-methylamine (~33 ppm) and dimethylamine groups (~43 ppm).  
Only three of the seven reactive sites were dimethylated as indicated by the numbers on the spectra 
in Figure 3.2.  Of those three, the amine corresponding to peak 7 was the most highly modified 
(Figure 3.2b). 
 
Figure 3.2.  NMR spectra of lysozyme reductively 13C-methylated with 7 moles of reactive amine 





The MALDI TOF-TOF MS analysis of the partially, reductively 13C-methylated pH 6.0 
sample shows two peptides corresponding to the N-terminus of the protein.  The peptide with a 
mass-to-charge ratio (m/z) of 634 corresponds to the N-terminal peptide (K(CH3)2VFGR) with two 
of the four methyl groups, and the peptide with 662 m/z corresponds to the peptide with all four 
methyl groups (K(CH3)4VFGR).  The percent 
13C incorporation of the protein was calculated by 
both NMR and MS as described in the methods section.  The percentage of 13C incorporation for 
peak 6 (NMR) and peptide 634 (Figure 3.3b) were calculated with values of 32.9% and 33.3%, 
respectively. 
 
Figure 3.3.  MALDI mass spectrometry isotopic profile of peptide 634 from lysozyme reductive 
methylated with (a) natural abundance formaldehyde, (b) sub-stoichiometric 13C-formaldehyde 






In solution, the amino groups exist in equilibrium between the free amine and the conjugate 
acid, which is tunable with pH.  The reductive methylation reaction preferentially modifies the N-
terminal α-amine at pH 6.0 due to the lower acid dissociation constant (pKa) of the α-amine (~7)
17 
versus the ε-amines (~10).25  At pH 6.0 the equilibrium is drastically shifted to favor the conjugate 
acid; the α-amine has the highest concentration of free amine, the reactive form in the reductive 
methylation reaction.  At pH 10.0, the equilibrium favors the free amine.  Even though the α-amine 
with its lower pKa exists nearly entirely in the free amine form, the ε-amines are stronger bases 
and more reactive.  In the presence of limiting 13C-formaldehyde, we are able to take advantage of 
the differing rates of reaction between the ε-amines and the α-amine.  The weaker nucleophilic 
nature of the α-amine resulted in lower -13C-dimethylamine as is observed in Figure 3.1c for peak 
7.  By using a correlation experiment (1H-13C HSQC), we were able to resolve the resonances 
without denaturing the protein such as the protocol used by Gerken et al.      
The high pH sample was also used to identify the NMR peak corresponding to the side-
chain -dimethylamine of Lys1.  Since the N-terminal side-chain -amino group is selectively 
labeled over the -amino group, the mass spectrum of the N-terminal tryptic peptide 634 was used 
to determine the percentage of 13C-incorporation for the -dimethylamine (33.3%).  This 
percentage corresponds to the percentage of 13C-incorporation calculated from the peak area of 
peak 6 (32.9%) in the NMR spectrum (Figure 3.1c), identifying peak 6 as the -dimethylamine of 
Lys1. 
3.5 Conclusions 
Two methods are introduced to assign the NMR signals of the α-dimethylamine and the 





assigning signals from any N-terminal -dimethylamine and a lysine -dimethylamine near the N-
terminus.  The low/high pH method can be applied without further manipulation of the sample 
when 2D 1H-13C NMR spectra provide resolved signals.  Another advantage of the low/high pH 
method is the protein remains intact, minimizing the possibility of structure degradation.  With the 
N-terminal α-amine and Lys1 side-chain ε-amine identified in the NMR spectrum, further studies 
are currently being performed with partially 13C-labeled protein to unambiguously assign the other 
dimethylamine resonances with their respective lysine residues. 
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CHAPTER 4 SYNTHESIS AND APPLICATION OF PROTEIN MODIFIER AS A 
GLYCOSYLATION MIMETIC AND CROSS-LINKING AGENT 
4.1 Introduction 
Chemical modification is a formidable approach, based on the orthogonal reactivities of 
amino acids, used to manipulate and mimic protein structure and function.  Understanding the 
relationship between protein structure and function has been the target for many biological studies 
today,1-5 particularly in regards to their use in application-driven technologies.  The advent of 
specialized reagents, advanced methods, and novel chemical reactions specific to certain amino 
acid side chains has driven this field from a restricted set of reactions with irrepressible results to 
a well-rounded arsenal of selective chemistries.  Chemical modification approaches have not only 
contributed to protein structure and function, but to enzyme catalysis,6-9 post-translational 
modification (PTM) mimetics,10 protein cross-linking for protein-protein interaction studies,11-13 
analytical methods such as mass spectrometry,14-17 and the development of new therapeutics.18 
In nature, proteins are modified through a host of enzymes to induce either co- or post-
translational modifications that are critical to protein activity.  Fundamental studies have imparted 
the role of these enzymes in the in vivo chemical modification of target proteins and cooperative 
recombinant expression systems that allow for their large-scale production.  However, the 
necessary post translational modification of glycosylated proteins (50 % of eukaryotic proteins) is 
not amenable in prokaryotic systems and prohibitively expensive in eukaryotic systems; requiring 
other means for production.  To mimic the glycosylation PTM of proteins expressed in bacterium 
or other prokaryotic systems, glycan groups are incorporated on the target protein using reactive 
chemistries and site-selective strategies.10,19  Typically, cysteine (-SH) and lysine (-NH2)  side 





research efforts exploiting the unconventional side chain functionalities of unnatural amino 
acids.20  Site-selective glycosylation has been pursued using the following approaches: 1) 
synthesizing complex glycans before coupling to the protein;21-22 2) coupling a single glycan and 
using glycosyltransferases to produce complex, synthetic glycoproteins;23 and 3) attaching 
covalent polymers, like poly(ethylene glycol), instead of a glycan.24  Each of these approaches has 
facilitated studies to understand the effects of glycosylation in proteins, improved resistance to 
enzymatic degradation, increased protein solubility and/or bioavailability, and prolonged protein 
drug half-life, making therapeutics based upon glycosylated proteins more robust.  
Chemical cross-linking of proteins has been essential in understanding protein-protein 
interactions and complex biological processes.  Similar chemistries used to mimic PTMs at 
cysteine or lysine residues can be used to functionalize proteins at more than one site.  This method 
allows multiple peptides and proteins to become “linked” using site-selective reagents and offers 
a versatile approach that directly identifies subsequent protein-protein interactions.25  In fact, 
elucidating the locations of disulfide bonds at cystine residues, the major naturally occurring cross-
linkage in proteins, has been an important step in solving tertiary structures in insulin, lysozyme, 
ribonuclease, and chymotrypsin.25  Preservation of structure, stability, and functionality of proteins 
and enzymes has largely benefited from advances in cross-linking chemical modification.26-29  
However, chemical reagents to date are unilateral and only permit molecular incorporation or 
protein-protein binding at select amino acid sites, but are not able to do both.  In this chapter, we 
present the synthesis of a protein modifier and preliminary data on its application as a glycosylation 





4.2 Materials and Methods 
Diacetone-D-glucose, sodium hydride, carbon disulfide, iodomethane, tributyltin hydride, 
sodium periodate, imidazole, tetrahydrofuran, toluene, methanol, acetic acid, ethyl acetate, 
hexanes, petroleum ether, acetonitrile, sodium bicarbonate, magnesium sulfate, and chloroform 
were obtained from Sigma-aldrich.  All solvents were used as received without further distillation. 
The NMR 1H and 13C spectra were collected on a Bruker DPX-250 at 250 and 62.5 MHz 
respectively.  1H spectra were collected with a relaxation delay of 5 seconds, 4 scans, and a 6000 
Hz spectral width.  13C spectra were collected with a relaxation delay of 5 seconds, 1000 scans, 
and a 15723 Hz spectral width.  2D NMR spectra were collected on a Varian 700 MHz equipped 
with a 5 mm-HCN-5922 probe.  2D NMR spectra were collected with a relaxation delay of 5s, 256 
scans, and a 4529 spectral width.  TMS was used as a standard for the 1H and 13C spectra and DSS 
was used for 2D experiments. 
Mass spectrometry data was acquired using a Bruker UltrafleXtreme MALDI-TOF-TOF 
instrument equipped with a Nd:YAG in linear mode, with 89-92% laser energy, and an average of 
4 x 500 shots.  The spectra were smoothed using the Savitzky-Golay algorithm, the baseline was 
subtracted, and the apex peak was manually selected using the Bruker FlexAnalysis software. 
4.2.1 Experimental 
4.2.2 Coupling the protein modifier to Lysozyme 
 To an aqueous solution of lysozyme (5 mg/mL), DMAB (6.13 μL of 1 M) was added, 
followed by protein modifier (3.5 mg, 20.2 mol).  The mixture was shaken at 4°C for 4 hours.  A 
second aliquot of DMAB was added, and the mixture was shaken at 4°C for an additional 24 hours.  






Note: Reactions with 1:10, 1:5 and 1:1 molar ratios produced little to no modification, in 
decreasing order. 
4.2.3 Synthesis of 1,2-O-isopropylidene-α-D-glucofuranose-5-carbaldehyde 
1,2:5,6-Di-O-isopropylidene-3-O-(S-methylxanthate)-α-D-glucofuranose 2: Diacetone-
D-glucofuranose (4.08 g, 7.68 mmol), imidazole (4.0 mg, 0.0282 mmol), tetrahydrofuran (80 mL), 
and a magnetic stir bar were added to a 500 – mL round-bottom flask.  The reaction vessel was 
flushed with nitrogen and a nitrogen atmosphere was maintained during the following steps.  60 
% Sodium hydride dispersion (1.23 g, 51.2 mmol) was added over time at 0 °C.  Vigorous bubbling 
was observed and reaction mixture turned cloudy.  After the reaction was stirred for 30 min, carbon 
disulfide (2.80 mL/3.55 g, 46.6 mmol) was added.  The reaction mixture turned yellow.  The 
reaction was stirred for 45 min, and then iodomethane (1.92 mL/4.37 g, 30.8 mmol) was added.  
The reaction mixture turned orange.  The reaction mixture was stirred for an additional 20 min. 
Glacial acetic acid was added drop wise until vigorous bubbling ceased.  The solution was filtered 
and concentrated on a rotary evaporator.  The residue was dissolved in 100 mL of ethyl acetate 
and washed with two, 50 mL portions of saturated sodium bicarbonate.  The ether solution was 
dried over magnesium sulfate, and the solvent was removed by rotary evaporation.  The resulting 
orange syrup was purified using a flash column (hexane-ethyl acetate 10:1) to give 2 as a yellow 
syrup; 1H NMR (250 MHz, CDCl3):  5.89 - 5.90 (m, 2H), 4.67 (d, J = 3.82, 1H), 4.43 – 4.19 (m, 
2H), 4.17 – 3.93 (m, 2H), 2.58 (s, 3H), 1.53 (s, 3H), 1.41 (s, 3H), 1.31 (d, J = 2.6 Hz, 6H); 13C 
NMR (62.5 MHz, CDCl3):   214.64, 112.28, 109.22, 104.90, 84.08, 82.65, 79.61, 72.23, 66.81, 
26.68, 26.52, 26.11, 25.12, 19.18; ESI-MS: m/z 351 [M + H+] 
3-Deoxy-1,2:5,6-di-O-isopropylidene-α-D-glucofuranose 3: A 100 mL round-bottom flask 





a nitrogen atmosphere.  Tributyltin hydride (1.49 g, 5.13 mmol) in 10 mL of anhydrous toluene 
was added.  Xanthate (1.0 g, 2.85 mmol) in 10 mL of toluene was added over time.  The reaction 
mixture was heated at reflux until TLC analysis indicated the disappearance of starting materials 
(approximately 7 h).  The reaction solution changed from deep yellow to nearly colorless.  Toluene 
was removed by rotary evaporation and the oily residue was partitioned between 100 mL portions 
of petroleum ether and acetonitrile.  The acetonitrile layer was separated and washed with three, 
50 mL portions of petroleum ether and then concentrated on a rotary evaporator.  The yellow oil 
was taken up in hexane-ethyl acetate (10:1) and filtered.  The filtrate was concentrated and the oil 
was purified using a flash column (hexane-ethyl acetate 3:1) to give (450 mg, 65 %) 3 as a colorless 
syrup; 1H NMR (250 MHz, CDCl3):   5.80 (d, J = 3.7 Hz, 1H), 4.74 (dd, J = 4.8, 3.7 Hz, 1H), 
4.37 – 3.91 (m, 4H), 3.80 (td, J = 4.3, 2.5 Hz, 1H), 2.17 (dd, J = 13.4, 4.0 Hz, 1H), 1.94 – 1.67 (m, 
1H), 1.49 (s, 3H), 1.40 (s, 3H), 1.34 (s, 3H), 1.30 (s, 3H); 13C NMR (62.5 MHz, CDCl3):  111.15, 
109.49, 105.44, 80.27, 78.47, 76.64, 67.02, 35.06, 26.61, 26.31, 25.98, 25.01; ESI-MS: m/z 245 
[M + H+]. 
3-Deoxy-1,2-O-isopropylidene-α-D-glucofuranose 4: To a stirred solution of 3-
deoxyglucofuranose (200 mg, 0.819 mmol) in methanol (2.8 mL) was added 0.8 % H2SO4 solution 
(700 µL).  After completion of the reaction, a saturated NaHCO3 (3 mL) solution was added after 
which methanol was removed under reduced pressure.  It was extracted into chloroform (5 x 10 
mL) and dried over anhydrous MgSO4.  Solvent was removed under vacuum, and the residue was 
purified by flash column chromatography (hexane/ethyl acetate = 1:9) to afford (139 mg, 83 % 
yield) 4 as a white solid; 1H NMR (250 MHz, CDCl3):  5.78 (d, J = 3.7 Hz, 1H), 4.73 (t, J = 4.2 
Hz, 1H), 4.20 (dt, J = 10.8, 4.4 Hz, 1H), 3.98 – 3.79 (m, 1H), 3.77 – 3.46 (m, 2H), 2.79 (s, 1H), 





1.30 (s, 3H); 13C NMR (62.5 MHz, CDCl3):  111.20, 105.00, 80.41, 78.44, 71.91, 63.36, 33.49, 
26.57, 25.95; ESI-MS: m/z 227 [M + H+]. 
1,2-O-isopropylidene-α-D-glucofuranose-5-carbaldehyde 5: NaIO4 (131 mg, 0.613 
mmol) was dissolved in hot water (2.25 mL).  To a stirred solution of the diol (50 mg, 0.245 mmol) 
in ethanol (520 µL) was added the NaIO4 solution.  After completion of the reaction, ethanol was 
added dropwise until no more precipitate formed.  The solution was filtered and the ethanol was 
evaporated.  The mixture was extracted into chloroform (5 X 50 mL).  The organic layer was dried 
over magnesium sulfate and the solvent was removed by rotary evaporation.  The residue was 
purified by flash chromatography to give (17 mg, 40 % yield) 5; 1H NMR (250 MHz, CDCl3):  
9.78 (d, J = 2.0 Hz, 1H), 6.03 (d, J = 3.6 Hz, 1H), 5.97 – 5.81 (m, 1H), 4.84 (dt, J = 15.7, 4.2 Hz, 
1H), 2.04 (dd, J = 13.4, 4.5 Hz, 1H), 1.82 (ddd, J = 13.5, 10.7, 4.7 Hz, 1H), 1.49 (s, 3H), 1.30 (s, 
3H); 13C NMR (62.5 MHz, CDCl3):  203.76, 112.71, 104.11, 83.32, 79.47, 35.77, 27.34, 25.38; 
ESI-MS: m/z 173 [M + H+]. 
4.3 Results and Discussion 
4.3.1 Synthesis of 1,2-O-isopropylidene-3-deoxy-5-pentafuranal  
Synthesis of 1,2-O-isopropylidene-3-deoxy-5-pentafuranal was achieved with an initial 
Barton-McCombie deoxygenation of diacetone-D-glucofuranose 1 (Scheme 4.1).  The secondary 
alcohol of 1 was converted to an S-methyl dithiocarbonate (xanthate) of 2.  Deoxygenation was 
completed by reacting 2 with tributylstannane via a radical process to give the 3-deoxy-
glucofuranose 3.  When stirred at room temperature in 0.8 % sulfuric acid, the 3-deoxy-
glucofuranose 3 was converted to the diol 4 without hydrolysis of the sterically hindered acetonide.  






Scheme 4.1.  Reagents and conditions: (a) NaH, CS2, MeI, anhydrous THF, quantitative yield; (b) 
Bu3SnH, toluene, reflux, 65%; (c) 0.8% aqueous H2SO4, MeOH, rt, 83%; (d) NaIO4, EtOH, H2O, 
40% 
4.3.2 Coupling the Modifier to Lysozyme 
Hen egg-white lysozyme was modified with the aldehyde 5 via reductive alkylation.  
Reaction times of the reductive alkylation reaction are directly correlated to the size of the carbonyl 
compound, in this case the aldehyde.  Reductive alkylation of lysozyme with formaldehyde, the 
smallest aldehyde, is reacted between 18 to 24 hours at 4 °C with dimethylamine borane to 
completely modify the protein, so reaction times exceeding 24 hours are expected for this reaction.  
The completeness of the reaction is heavily dependent on the reducing agent and concentration of 
the aldehyde.  In addition to reducing the Schiff base, reducing agents can reduce the aldehyde to 
an alcohol in a competing reaction.  Stronger reducing agents have a higher rate of the competing 
reaction.  Reacting the protein with 20 molar excess of the aldehyde (compared to reactive amines 
in the protein) for five days at 4 °C with dimethylamine borane yielded the highest degree of 
modification as shown by MALDI-TOF analysis (Figure 4.1a).  The mass-to-charge (m/z) ratio of 
16162.9 corresponds to 10 aldehydes being coupled to lysozyme, which has 7 reactive amines; 
therefore, some sites have multiple aldehydes coupled to the lysine side chain amine.  Reactions 






Figure 4.1.  MALDI-TOF analysis of a) protein modifier coupled to hen egg white lysozyme and 
b) hen egg white lysozyme cross-linked with protein modifier. 
reactive amine ratios produce minimum to no modification.  The protein sample was then analyzed 
by NMR spectroscopy.  2D 1H-13C heteronuclear single quantum coherence (HSQC) NMR 
spectrum of the modified protein was compared to the spectrum of unmodified lysozyme (Figure 
4.2).  Overlay of the two spectra showed the appearance of two new peaks in the methyl region of 
the spectra corresponding to the acetonide methyls of the protein modifier, confirming its addition 
to lysozyme.  The new peaks integrated to a 1:1 ratio with the other isolated methyl peaks in the 
spectrum, which conflicts with the MALDI data.  Integration of the peaks and similar chemical 
shifts suggest they are from the same modification, in which case there should be 9 more pairs 
according to the MALDI spectrum.  Although conflicting, NMR and MALDI analysis revealed 
modification of the protein.  Additionally, overlap of the NMR signals of modified and unmodified 
lysozyme suggested minimum structural perturbations due to the modification. 
4.3.3 Glycosylation Mimetic 
Application of the protein modifier as a glycosylation mimetic requires the removal of the 
acetonide protecting group of the 1,2 diol of the aldehyde.  Once the protecting group is removed 






Figure 4.2.  Overlay of 2D 1H-13C HSQC spectra of (red) native lysozyme and (green) lysozyme 
coupled to the protein modifier. 
furanose ring and the straight chain glucose derivative, which has a terminal aldehyde.  Subsequent 
intramolecular reductive alkylation will give the desired cyclic product for glycosylation mimetics.  
However, there is the possibility of an intermolecular reductive alkylation with another lysozyme 
molecule (Scheme 4.2).  The rate of hydrolysis of the 1,2-O-alkylidene--glucofuranose (the 
parent compound of the aldehyde derivative) has a half-life of 20 hours in dilute sulfuric acid.30  
The pH of those conditions is less than 1, which is extremely harsh for the protein and would cause 
denaturation.  However, lysozyme can survive at pH 4.0 for 1 week at 4 °C before denaturation.  
The protein sample was diluted to 2.5 mg/mL in phosphate buffer at pH 4.0 and stirred at 55 °C 
for five days for deprotection.  The methyl region of the 1H-13C HSQC NMR spectrum was 
analyzed to confirm the removal of the acetonide and showed a decreased intensity of the two 






Scheme 4.2.  Schematic of the second alkylation reaction for cross-linking and intramolecular 
reaction. 
protecting group methyls (Figure 4.3).  The sample was also analyzed by sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) to access how much of the protein had cross- 
linked (Figure 4.4).  Analysis of the protein gel reveals a faint band around 30 kDa for cross-linked 
protein and a significantly more intense band around 16 kDa for the modified protein. 
4.3.4 Protein Cross-linking 
To date, there is not a single compound used as both a glycomimetic and a protein cross-
linking agent.  Experiments were conducted to assess the possibility of this glucose derivative 
performing as both.  Whether the intramolecular or intermolecular reaction occurs depends on the 
conditions immediately following the removal of the acetonide protecting group.  The protein 





protein molecules to induce cross-linking.  Upon completion of the deprotection, the pH was 
adjusted to neutral and the sample was stirred at 4°C for two days.  Initial attempts to cross-link  
 
Figure 4.3.  2D 1H-13C HSQC of modified lysozyme after removal of the acetonide protecting 
group. 
lysozyme were not successful.  However, one experiment, produced a higher order species as 
analyzed by MALDI-TOF (Figure 4.1b).  The shape of the cross-linked protein peak in the mass 
spectrum was odd with spikes and a width of 1500 mass units.  The m/z values of the spikes in the 
peak appear random and do not clearly correspond to different correspond to units of modification.  
The sample was also analyzed by SDS-PAGE revealing a band around 30 kDa, corresponding to 
cross-linked dimer (Figure 4.4) with 20 total protein modifiers coupled.  It must be noted that the 
solvent dried up during the deprotection of the sample that produced the higher order species.  
These results taken together suggest that the intermolecular cross-linking reaction is not very 






Figure 4.4.  1D gel protein profile of unmodified lysozyme (lane 4), modified lysozyme after the 
second reductive alkylation reaction (lane 3), and the cross-linked lysozyme sample (lane 2). 
4.4 Conclusions 
We have presented the synthesis of 1,2-O-isopropylidene-3-deoxy-5-pentafuranal and 
preliminary results of its use to modify proteins.  The protein modifier has demonstrated potential 
as a glycosylation mimetic.  The intramolecular reaction of the same amine creates a cyclic 
modification on the lysine side chain and/or N-terminal amine.  The cyclic modification of proteins 
with this reagent mimics the structure of a glycan and is a potential site for elongation of complex 
glycans through glycosyltransferases.  Mimicking the structure of sugar molecules may have an 
added benefit over current glycomimetics (i.e. polyethylene glycol) of lower toxicity.  This 
modification also has potential to be used as a modification of protein drugs to prevent premature 





Successful coupling of the modifier to lysozyme was demonstrated.  However, the reaction 
with 20 molar excess of the modifier produced a less than optimal lysozyme sample (7 reactive 
amines) with 10 modifications.  Ideally, a single alkylation at any reactive site of the protein is 
desired to accommodate the subsequent intramolecular reaction of the same amine for application 
as a glycosylation mimetic. 
The intramolecular reaction was shown to occur without significant competition from 
intermolecular cross-linking.  While intermolecular cross-linking was not an issue, it is possible 
that intramolecular cross-linking occurred between two lysine residues rather than the cyclization 
reaction.  Further analysis is necessary to demonstrate that the targeted intramolecular, cyclization 
reaction occurred and the aldehyde acts as a glycosylation mimetics. 
Intermolecular cross-linking with this reagent was not efficient.  Although a cross-linked 
dimer was created, it was most likely facilitated by the evaporation of the solvent during the 
reaction; previous attempts, in which the solvent had not evaporated, failed to produce cross-linked 
protein.  Production of the dimer with evaporated solvent was also inefficient as analyzed by 
protein gel electrophoresis, with an equally intense band around 16 kDa for modified protein and 
no higher order oligomers observed.  Other conditions are necessary if the presented protein 
modifier is to be used as a cross-linking agent. 
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CHAPTER 5 CONCLUSIONS AND FUTURE STUDIES 
5.1 Concluding Remarks 
Orthogonal chemical modifications are the key to completely understanding the roles of 
protein function in biological activity.  Typically, this is accomplished through X-ray 
crystallography and activity assays.  However, those methods do not provide an in-solution 
perspective of protein structure or direct correlation to change in activity, respectively.  NMR 
spectroscopy offers a means to provide an in-solution snapshot of proteins, in which specific amino 
acid residues can be correlated to structural and functional perturbations.  In this dissertation, we 
used hen egg white lysozyme as a model protein to study in depth reductive alkylation of lysine 
residues to improve NMR methodologies for protein structural studies. 
In Chapter 2, the development of chemical modification methodologies for ultimate protein 
structural studies were presented.  Crown ether (18C6) was used as a reagent to selectively alter 
the reaction rates of lysine side chain amines, however, the crown ether only showed effects in 
concentrations of excess and had a universal effect on all sites.  A second method utilized the 
varying strengths and hydrophobicities of different reducing agents to alter the rates of the side 
chain amines.  Although proven effective, the degeneracy in 13C incorporation was not overcome 
to assign lysine dimethylamino NMR resonances.  The third method presented in this chapter 
aimed to develop a non-destructive Edman degradation to cleave the N-terminal amino acid for 
identification and assignment of dimethylamino resonances of lysine 1.  Cleavage of the N-
terminal residue without denaturation of the protein proved elusive, thereby, rendering this method 
inoperable. 
In Chapter 3, we presented a method to identify and assign both the - and -dimethylamino 





based on a pH induced chemoselectivity of the reductive methylation reaction, in which the -
amine reacted at a faster rate than the side chain -amines at pH 6.0 and vice versa at pH 10.0.  
This method made it possible to obtain an individual isotope incorporation measurement for the -
amine of an N-terminal lysine residue, which had previously never been accomplished. 
In Chapter 4, the synthesis and application of 1,2-O-isopropylidene-3-deoxy-5-pentafuranal 
as a protein modifier was discussed.  Preliminary results show the potential of this individual 
reagent as a glycomimetic; however, its use as a cross-linking agent does not seem viable. 
5.2 Future Studies 
To date, many approaches to chemically modify proteins for structural and functional gains 
have been used.  We have successfully developed a method to identify and assign N-terminal 
dimethylamino NMR resonances as well as synthesized a protein modifier with dual application.  
However, this work only scratches the surface of the larger problems they target. 
The need to make absolute assignments of NMR resonances without extensive prior 
knowledge of the target protein makes the N-terminal assignment strategy valuable.  However, 
more work is needed to overcome the degenerate isotope incorporation problem with the mass 
spectrometry assisted assignment strategy.  Degenerate modification necessitates advancements in 
altering the rates of reaction at selective sites.  Therefore, reductive methylation in the presence of 
ligands may be suitable for this effort.  In this manner, lysine residues shielded by the bound ligand 
or structural perturbations due to binding are not modified as extensively as those not affected by 
the binding of the ligand. 
The presentation of the protein modifier clearly demonstrated application as a protein 
modifier.  However, future work on the optimization of the coupling of the modifier to the protein 





produced a sample with 10 modifications.  Lysozyme has 7 reactive sites, 6 lysines and the -
amine.  This extent of modification is not optimal for use as a glycosylation mimetic.  Ideally, the 
protein should have no more than 7 modifications to facilitate the cyclization reaction for the 
glycosylation mimicking modification.  Also, future studies on the characterization of the modified 
product is needed for confidence that the desired modification occurred.  MS/MS may be the best 
option for mapping the location of modification of the protein.  The utility of this reagent as a 
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